Table Of Content

Author Index to Volume 16* A Andreu H (see Corrales et al). 1992;16:1922-7 Abreu L (see Girén et al). 1992;16:664-70 —— (see Giménez et al). 1992;16:815-9 —— (see Menéndez et al). 1992;16:931-6 Andus T, Gross V, Holstege A, Ott M, Weber M, David M, Abuaf N, Johanet C, Chretien P, Martini E, Soulier E, Gallati H, Gerok W, Schélmerich J. High concentrations Laperche S, Homberg JC. Characterization of the liver of soluble tumor necrosis factor receptors in ascites. cytosol antigen type 1 reacting with autoantibodies in 1992;16:749-55 chronic active hepatitis. 1992;16:892-8 Angeli P, Caregaro L, Menon F, Sacerdoti D, De Toni R, Merkel —— (see Lunel et al). 1992;16:630-6 C, Gatta A. Variability of atrial natriuretic peptide Ackerman Z, Valinluck B, McHutchison JG, Redeker AG, plasma levels in ascitic cirrhotic patients: pathophysio- Govindarajan S. Spontaneous exacerbation of disease logical and clinical implications. 1992;16:1389-94 activity in patients with chronic delta hepatitis infection: Angus PW (see Dixon et al). 1992;16:943-8 The role of hepatitis B, C or D? 1992;16:625-9 Annoni G (see Torgano et al). 1992;16:19-23 Acs G (see Price et al). 1992;16:8-12 Aoki K (see Okada et al). 1992;16:112-7 Adachi E (see Utsunomiya et al). 1992;16:694-701 Appelman HD (see Henley et al). 1992;16:688-93 Adachi H, Kaneko S, Matsushita E, Inagaki Y, Unoura M, Aragona E (see Vemuru et al). 1992;16:968-73 Kobayashi K. Clearance of HBsAg in seven patients with Arias IM (see Huang et al). 1992;16:756-62 chronic hepatitis B. 1992;16:1334-7 Arias J (see Landa et al). 1992;16:1474-6 Adams DH, Mainolfi E, Burra P, Neuberger JM, Ayres R, Elias Arnold JC, Portmann BC, O’Grady JG, Naoumov NV, Alex- E, Rothlein R. Detection of circulating intercellular ander GJM, Williams R. Cytomegalovirus infection adhesion molecule-1 in chronic liver diseases. 1992;16: persists in the liver graft in the vanishing bile duct 810-4 syndrome. 1992;16:285-92 Aharonson S (see Tur-Kaspa et al). 1992;16:1338-42 Arosio E (see Torgano et al). 1992;16:19-23 Ahlberg J (see Sahlin et al). 1992;16:320-6 Arroyo V (see Llach et al). 1992;16:724-7 Akahane Y (see Machida et al). 1992;16:886-91 Arthur MJP (see Kowalski-Saunders et al). 1992;16:733-41 —— (see Okada et al). 1992;16:619-24 Asakura H (see Nomoto et al). 1992;16:1199-1205 Ala-Kokko L, Giinzler V, Hoek JB, Rubin E, Prockop DJ. Ascher N (see Ferrell et al). 1992;16:865-76 Hepatic fibrosis in rats produced by carbon tetrachloride Ascher NL (see Lidofsky et al). 1992;16:1-7 and dimethylnitrosamine: observations suggesting im- —— (see Ferrell et al). 1992;16:1372-81 munoassays of serum for the 7S fragment of type IV Askari F, Wilson J. Provocative gene therapy strategy for the collagen are a more sensitive index of liver damage than treatment of hepatocellular carcinoma. 1992;16:273-4 immunoassays for the NH,-terminal propeptide of type (HEPATOLOGY Elsewhere) III procollagen. 1992;16:167-72 Assaisso M (see Colombo et al). 1992;16:924-30 Albano E (see Parola et al). 1992;16:1014-21 Audet R (see Swain et al). 1992;16:1028-35 Alberti A (see Fattovich et al). 1992;16:1115-9 Axiotis CA (see Di Bisceglie et al). 1992;16:649-54 Albillos A (see Girén et al). 1992;16:664-70 Aydemir U (see Beuers et al). 1992;16:707-14 —— (see Lee et al). 1992;16:1043-8 Ayres R (see Adams et al). 1992;16:810-4 —— (see Menéndez et al). 1992;16:931-6 Ayuso C (see Vilana et al). 1992;16:353-7 Alexander GJM (see Arnold et al). 1992;16:285-92 Azzarone A (see Francavilla et al). 1992;16:1267-70 Alié S (see Giménez et al). 1992;16:815-9 Aligué R (see Bastos et al). 1992;16:1434-46 B Alvarez A (see Cascales et al). 1992;16:232-40 Alvarez L (see Corrales et al). 1992;16:1922-7 Bach GG (see Goresky et al). 1992;16:173-90 Alvarez-Mon M (see Girén et al). 1992;16:664-70 —— (see Kassissia et al). 1992;16:763-75 —— (see Menéndez et al). 1992;16:931-6 Bachs O (see Bastos et al). 1992;16:1434-46 Anciaux M-L (see Ink et al). 1992;16:912-9 Back N, Bodenheimer HC Jr. Transmission of hepatitis C: Anderson JV (see Panos et al). 1992;16:82-8 Sexual, vertical or exclusively blood-borne? 1992;16: Andre C (see Briand et al). 1992;16:1395-1403 1497-9 (HEPATOLOGY Elsewhere) —— (see Pawlotsky et al). 1992;16:127-31 Bacon BR (see Kamimura et al). 1992;16:448-53 Andreone P, Cursaro C, Gasbarrini G. Interferon-a therapy Baker JR Jr. The immune response in chronic hepatitis B virus combined with nonsteroid antiinflammatory drugs for infection: The “‘core”’ of the problem? 1992;16:498-500 treatment of chronic viral hepatitis? 1992;16:505 (Hepatology Elsewhere) —— (see Bernardi et al). 1992;16:341-6 Bakker CM, Metselaar HJ, Groenland TN, Gomes MJ, Knot EAR, Hesselink EJ, Schalm SW, Stibbe J, Terpstra OT. Increased tissue-type plasminogen activator activity in *July, 1-284; August, 285-618; September, 619-860; October, 861-1108; orthotopic but not heterotopic liver transplantation: the November, 1109-1314; December, 1315-1510. role of the anhepatic period. 1992;16:404-8 1513 1514 AUTHOR INDEX HEPATOLOGY Balabaud C (see Bioulac-Sage et al). 1992;16:418-25 phospholipid fatty acid species with cholesterol satu- Balanzé J (see Kulisevsky et al). 1992;16:1382-8 ration of duodenal bile in health and gallstone disease. Baldwin D (see Sallie et al). 1992;16:1206-11 1992;16:71-81 Balibrea JL (see Landa et al). 1992;16:1474-6 Beuers U, Spengler U, Kruis W, Aydemir U, Wiebecke B, Baliga P (see Henley et al). 1992;16:688-93 Heldwein W, Weinzierl M, Pape GR, Sauerbruch T, Banerjee R (see Price et al). 1992;16:8-12 Paumgartner G. Ursodeoxycholic acid for treatment of Banks RK (see Fowler et al). 1992;16:1187-94 primary sclerosing cholangitis: a placebo-controlled trial. Baraldini M (see Bernardi et al). 1992;16:341-6 1992;16:707-14 Barbara C (see Barbara et al). 1992;16:132-7 Bhargava DK (see Dasarathy et al). 1992;16:89-94 Barbara L, Benzi G, Gaiani S, Fusconi F, Zironi G, Siringo S, Bhist MS (see Sushma et al). 1992;16:138-44 Rigamonti A, Barbara C, Grigioni W, Mazziotti A, Bhunchet E, Wake K. Role of mesenchymal cell populations in Bolondi L. Natural history of small untreated hepato- porcine serum-—induced rat liver fibrosis. 1992;16: cellular carcinoma in cirrhosis: a multivariate analysis of 1452-73 prognostic factors of tumor growth rate and patient Biagini MR (see McCormick et al). 1992;16:1180-6 survival. 1992;16:132-7 Bianchi G (see Marchesini et al). 1992;16:149-55 Barisani D (see Mandelli et al). 1992;16:956-9 Bianchi L (see Hornstein et al). 1992;16:217-23 Barker F III (see Goresky et al). 1992;16:173-90 Biasi F (see Parola et al). 1992;16:1014-21 Barnett JL. Cholangitis and endoscopic drainage. 1992;16: Bilzer M (see Gerbes et al). 1992;16:790-3 1302-3 (HEPATOLOGY Elsewhere) Biocca ME (see Parola et al). 1992;16:1014-21 Barrett-Bergshoeff MM (see Otter et al). 1992;16:54-9 Bioulac-Sage P, Dubuisson L, Bedin C, Gonzalez P, de Tinguy- Bartula L (see Myers and Bartula). 1992;16:1176-9 Moreaud E, Garcin H, Balabaud C. Nodular regenerative Bass NM (see Lidofsky et al). 1992;16:1-7 hyperplasia in the rat induced by a selenium-enriched Bassendine MF (see Challen et al). 1992;16:1362-6 diet: study of a model. 1992;16:418-25 Bastos R, Engel P, Pujades C, Falchetto R, Aligué R, Bachs O. Bissuel F, Bizollon T, Dijoud F, Bouletreau P, Cordier JF, Increase of cytokeratin D during liver regeneration: Chazot C, Gouillat C, Trepo C. Pulmonary hemorrhage association with the nuclear matrix. 1992;16:1434-46 and glomerulonephritis in primary biliary cirrhosis. Battezzati PM (see Colombo et al). 1992;16:924-30 1992;16:1357-61 Bauditz J (see Kénig et al). 1992;16:1137-43 Bizollon T (see Bissuel et al). 1992;16:1357-61 Beaugrand M (see Pawlotsky et al). 1992;16:127-31 Blei AT (see Coy et al). 1992;16:278-9 (Letter) Bechstein WO (see Kénig et al). 1992;16:1137-43 —— (see Swain et al). 1992;16:1028-35 Becker M-C (see Bresson-Hadni et al). 1992;16:279-80 (Letter) Blendis LM. Hepatology Elsewhere: twenty years after! 1992; Bedin C (see Bioulac-Sage et al). 1992;16:418-25 16:1096-8 (HEPATOLOGY Elsewhere) Bedossa P (see Laurent-Puig et al). 1992;16:1171-5 —— (see Morali et al). 1992;16:42-8 Belghiti J (see Laurent-Puig et al). 1992;16:1171-5 Blumhardt G (see Konig et al). 1992;16:1137-43 Beloqui O (see Ruiz et al). 1992;16:637-41 Bodenheimer HC Jr (see Back and Bodenheimer). 1992;16: Belzer FO (see Kim et al). 1992;16:742-8 1497-9 (HEPATOLOGY Elsewhere) —— (see Vreugdenhil et al). 1992;16:241-6 Bolondi L (see Barbara et al). 1992;16:132-7 Bendtsen F (see Henriksen et al). 1992;16:1163-70 Bommineni VR (see Huang et al). 1992;16:756-62 Benzi G (see Barbara et al). 1992;16:132-7 Bonnefis M-T (see Calmus et al). 1992;16:719-23 Bergasa NV (see Di Bisceglie et al). 1992;16:649-54 Borotto E (see Lunel et al). 1992;16:630-6 Bergeron M (see Swain et al). 1992;16:1028-35 Bosca L (see Cascales et al). 1992;16:232-40 Berk PD. Guidelines for training in hepatology. 1992;16: Bouletreau P (see Bissuel et al). 1992;16:1357-61 1084-6 (Special article) Boyer JL (see Hayakawa et al). 1992;16:1036-42 — —. Redundant publication: déja vu all over again. 1992;16: Braillon A (see Soubrane et al). 1992;16:1447-51 840-2 (Editorial) Bray G (see Underhill et al). 1992;16:1404-8 — — (see Schiff et al). 1992;16:1087-8 (Editorial) Bresson-Hadni S, Miguet J-P, Lenys D, Vuitton D-A, Viennet Berkowitz CM. Does albumin regulate albumin? 1992;16: G, Becker M-C, Rohmer P, Mantion G, Gillet M. 1499-501 (HEPATOLOGY Elsewhere) Recurrence of alveolar echinococcosis in the liver graft Bernard O (see Devictor et al). 1992;16:1156-62 after liver transplantation. 1992;16:279-80 (Letter) Bernardi M, Di Marco C, Trevisani F, De Collibus C, Fornalé Briand J-P, Andre C, Tuaillon N, Herve L, Neimark J, Muller L, Baraldini M, Andreone P, Cursaro C, Zaca F, Ligabue S. Multiple autoepitope presentation for specific de- A, Gasbarrini G. The hemodynamic status of preascitic tection of antibodies in primary biliary cirrhosis. 1992; cirrhosis: an evaluation under steady-state conditions 16:1395-1403 and after postural change. 1992;16:341-6 Britton RS (see Kamimura et al). 1992;16:448-53 Berr F, Holl J, Jiingst D, Fischer S, Richter WO, Seifferth B, Broder S (see Fried et al). 1992;16:861-4 Paumgartner G. Dietary N-3 polyunsaturated fatty acids Brollo L (see Fattovich et al). 1992;16:1115-9 decrease biliary cholesterol saturation in gallstone Bronsther O (see Demetris et al). 1992;16:671-81 disease. 1992;16:960-7 Brown KA (see Henley et al). 1992;16:688-93 — —, Schreiber E, Frick U. Interrelationships of bile acid and Bru C (see Vilana et al). 1992;16:353-7 Vol. 16, No. 6, 1992 AUTHOR INDEX Bruix J (see Vilana et al). 1992;16:353-7 Chazot C (see Bissuel et al). 1992;16:1357-61 Buchholz U (see Hagmann et al). 1992;16:1477-84 Chen C-J, Zhang Y-J, Lu S-N, Santella RM. Aflatoxin B, DNA Bugianesi E (see Marchesini et al). 1992;16:149-55 adducts in smeared tumor tissue from patients with Burra P (see Adams et al). 1992;16:810-4 hepatocellular carcinoma. 1992;16:1150-5 Burroughs AK (see McCormick et al). 1992;16:1180-6 Chen C-L (see Wu et al). 1992;16:1120-7 Burtch GD (see Henley et al). 1992;16:688-93 Cherry WF (see Goresky et al). 1992;16:173-90 Butterworth RF (see Swain et al). 1992;16:1028-35 Chi C-W (see Chou et al). 1992;16:13-8 Chin J (see McCormick et al). 1992;16:1180-6 Chindemi PA (see Hu et al). 1992;16:1049-54 Cc Chisari FV (see Gilles et al). 1992;16:655-63 Caballeria J (see Corrales et al). 1992;16:1922-7 Chiu J-H (see Jwo et al). 1992;16:1367-71 —— (see Giménez et al). 1992;16:815-9 Chong MG (see Sussman et al). 1992;16:60-5 Cailmail S (see Sogni et al). 1992;16:980-3 Chou C-K, Wang L-H, Lin H-M, Chi C-W. Glucocorticoid Caldarelli R (see Fargion et al). 1992;16:1322-6 stimulates hepatitis B viral gene expression in cultured Caldwell SH, Leung PSC, Spivey JR, Prindiville T, de Medina human hepatoma cells. 1992;16:13-8 M, Saicheur T, Rowley M, Reddy KR, Coppel R, Jeffers Chretien P (see Abuaf et al). 1992;16:892-8 LJ, Mackay IR, Schiff ER, Gershwin ME. Antimitochon- Christensen NJ (see Henriksen et al). 1992;16:1163-70 drial antibodies in kindreds of patients with primary Cianciara J, Laskus T. Thymic factor X treatment of chronic biliary cirrhosis: antimitochondrial antibodies are hepatitis B. 1992;16:1507-8 (Letter) unique to clinical disease and are absent in asymp- Cillo U (see Francavilla et al). 1992;16:1267-70 tomatic family members. 1992;16:899-905 Clavien P-A (see Cywes et al). 1992;16:1271-9 Calmus Y, Guechot J, Podevin P, Bonnefis M-T, Giboudeau J, —— (see Strasberg and Clavien). 1992;16:820-39 (Special Poupon R. Differential effects of chenodeoxycholic and article) ursodeoxycholic acids on interleukin-1, interleukin-6 Coates PJ (see Palmer et al). 1992;16:682-7 and tumor necrosis factor-a production by monocytes. Colina I (see Lopez et al). 1992;16:162-6 1992;16:719-23 Collier J (see Challen et al). 1992;16:1362-6 Campbell C (see Mason et al). 1992;16:36-41 Colombato LA (see Lee et al). 1992;16:1043-8 Campbell DA Jr (see Henley et al). 1992;16:688-93 Colombo C, Crosignani A, Assaisso M, Battezzati PM, Podda Cantafora A (see Riggio et al). 1992;16:785-9 M, Giunta A, Zimmer-Nechemias L, Setchell KDR. Urso- Capdevilla A (see Kulisevsky et al). 1992;16:1382-8 deoxycholic acid therapy in cystic fibrosis—associated Capocaccia L (see Riggio et al). 1992;16:785-9 liver disease: a dose-response study. 1992;16:924-30 Cappellini MD (see Fargion et al). 1992;16:1322-6 Conte D (see Mandelli et al). 1992;16:956-9 Carbone D. The P53 “knockout”: gone but not forgotten. Contessini E (see Torgano et al). 1992;16:19-23 1992;16:1094-6 (HEPATOLOGY Elsewhere) Coppel R (see Caldwell et al). 1992;16:899-905 Cardin F (see McCormick et al). 1992;16:1180-6 —— (see Davis et al). 1992;16:1128-36 Caregaro L (see Angeli et al). 1992;16:1389-94 Corasanti J (see Hayakawa et al). 1992;16:1036-42 Cariani E (see Puoti et al). 1992;16:877-81 Cordier JF (see Bissuel et al). 1992;16:1357-61 Carreno V (see Ruiz-Moreno et al). 1992;16:882-5 Corrales F, Giménez A, Alvarez L, Caballeria J, Pajares MA, Carrieri G (see Francavilla et al). 1992;16:1267-70 Andreu H, Parés A, Mato JM, Rodés J. Cascales M, Martin-Sanz P, Alvarez A, Sanchez-Pérez M, S-adenosylmethionine treatment prevents carbon Fernandez CD, Bosca L. Isoenzymes of carbohydrate tetrachloride—-induced S-adenosylmethionine syn- metabolism in primary cultures of hepatocytes from thetase inactivation and attenuates liver injury. 1992; thicacetamide-induced rat liver necrosis: responses to 16:1922-7 growth factors. 1992;16:232-40 Cote P (see Diehl et al). 1992;16:1212-9 Caschera M (see Riggio et al). 1992;16:785-9 Coy DL, Zee P, Blei AT. Quantitating hepatic encephalopathy Castellano G (see Solis-Herruzo et al). 1992;16:974-9 in rats after portacaval anastomosis. 1992;16:278-9 Castelnuovo F (see Puoti et al). 1992;16:877-81 (Letter) Castillo I (see Ruiz-Moreno et al). 1992;16:882-5 Crabb DW. ADH1, 2 and 3: genes whose times have come. Castillo T, Koop DR, Kamimura S, Triadafilopoulos G, 1992;16:1501-3 (HEPATOLOGY Elsewhere) Tsukamoto H. Role of cytochrome P-450 2E1 in Crombie DL (see Esch et al). 1992;16:984-91 ethanol-, carbon tetrachloride— and iron-dependent mi- Crosignani A (see Colombo et al). 1992;16:924-30 crosomal lipid peroxidation. 1992;16:992-6 Crowther RS (see Qiu et al). 1992;16:1280-9 Ceneviva R (see Roselino et al). 1992;16:1055-60 Cuende JI (see Ruiz et al). 1992;16:637-41 Cesarini L (see Mandelli et al). 1992;16:956-9 Cursaro C (see Andreone et al). 1992;16:550 (Letter) Challen C, Lunec J, Warren W, Collier J, Bassendine MF. —— (see Bernardi et al). 1992;16:341-6 Analysis of the p53 tumor-suppressor gene in hepatocel- Cywes R, Greig PD, Morgan GR, Sanabria JR, Clavien P-A, lular carcinomas from Britain. 1992;16:1362-6 Harvey PRC, Strasberg SM. Rapid donor liver nutri- Chaput J-C (see Ink et al). 1992;16:912-9 tional enhancement in a large animal model. 1992;16: Chau G-Y (see Jwo et al). 1992;16:1367-71 1271-9 AUTHOR INDEX HEPATOLOGY D —— (see Wiesner et al). 1992;16:1290-9 (Special article) D’ Agostino HB (see Esch et al). 1992;16:984-91 Diehl AM, Yang SQ, Cote P, Wand GS. Chronic ethanol D’Aquilino E (see Riggio et al). 1992;16:785-9 consumption disturbs G-protein expression and inhibits Dasarathy S, Dwivedi M, Bhargava DK, Sundaram KR, cyclic AMP-dependent signaling in regenerating rat Ramachandran K. A prospective randomized trial com- liver. 1992;16:1212-9 paring repeated endoscopic sclerotherapy and pro- Dijoud F (see Bissuel et al). 1992;16:1357-61 pranolol in decompensated (Child class B and C) cir- Di Marco C (see Bernardi et al). 1992;16:341-6 rhotic patients. 1992;16:89-94 Dixon RM, Angus PW, Rajagopalan B, Radda GK. *'P Dasarathy S (see Sushma et al). 1992;16:138-44 magnetic resonance spectroscopy detects a functional David M (see Andus et al). 1992;16:749-55 abnormality in liver metabolism after acetaminophen Davies S (see Sallie et al). 1992;16:1206-11 poisoning. 1992;16:943-8 Davies SE (see Palmer et al). 1992;16:682-7 Dodson TF (see Henderson et al). 1992;16:715-8 Davis PA, Leung P, Manns M, Kaplan M, Munoz SJ, Gorin FA, Doherty DG (see Farrant et al). 1992;16:390-5 Dickson ER, Krawitt E, Coppel R, Gershwin ME. M4 and —— (see Underhill et al). 1992;16:1404-8 M9 antibodies in the overlap syndrome of primary biliary Donaldson PT (see Farrant et al). 1992;16:390-5 cirrhosis and chronic active hepatitis: Epitopes or —— (see Underhill et al). 1992;16:1404-8 epiphenomena? 1992;16:1128-36 Donovan JP, Shaw BW Jr, Langnas AN, Sorrell MF. Brain Debray D (see Devictor et al). 1992;16:1156-62 water and acute liver failure: the emerging role of intra- de Castro-e-Silva O Jr (see Roselino et al). 1992;16:1055-60 cranial pressure monitoring. 1992;16:267-8 (Editorial) De Collibus C (see Bernardi et al). 1992;16:341-6 —— (see Langnas et al). 1992;16:1303-5 (HEPATOLOGY De Feo ML (see La Villa et al). 1992;16:156-61 Elsewhere) de Franchis R (see Torgano et al). 1992;16:19-23 Douglas DD (see Rakela and Douglas). 1992;16:497-8 (P - \a- De Giacomo C (see Maggiore and De Giacomo). 1992;16:504 tology Elsewhere) (Letter) Dreher KL (see Meyer et al). 1992;16:204-16 Delhaye M, Gulbis B, Galand P, Mairesse N. Expression of Dubousset A-M (see Devictor et al). 1992;16:1156-62 27-kD heat-shock protein isoforms in human neoplastic Dubuisson L (see Bioulac-Sage et al). 1992;16:418-25 and nonneoplastic liver tissues. 1992;16:382-9 Dufour J-F, Gehr P, Reichen J. Hepatic accumulation of DelValle J (see Raper et al). 1992;16:433-9 lysosomes and defective transcytotic vesicular pathways De Marco M (see Guglielmi et al). 1992;16:1144-9 in cirrhotic rat liver. 1992;16:997-1006 de Medina M (see Caldwell et al). 1992;16:899-905 Durantez A (see Girén et al). 1992;16:664-70 Demetris AJ, Nakamura K, Yagihashi A, Iwaki Y, Takaya S, —— (see Menéndez et al). 1992;16:931-6 Hartman GG, Murase N, Bronsther O, Manez R, Fung Dwivedi M (see Dasarathy et al). 1992;16:89-94 JJ, Iwatsuki S, Starzl TE. A clinicopathological study of human liver allograft recipients harboring preformed E IgG lymphocytotoxic antibodies. 1992;16:671-81 — — (see Furuya et al). 1992;16:1415-22 Eddleston ALWF (see Farrant et al). 1992;16:390-5 Desmet VJ. Congenital diseases of intrahepatic bile ducts: Einarsson K (see Sahlin et al). 1992;16:320-6 variations on the theme “ductal plate malformation”’. Elias E (see Adams et al). 1992;16:810-4 1992;16:1069-83 (Special article) Elmore LW, Sirica AE. Sequential appearance of intestinal Desplanques L (see Devictor et al). 1992;16:1156-62 mucosal cell types in the right and caudate liver lobes of de Tinguy-Moreaud E (see Bioulac-Sage et al). 1992;16:418-25 furan-treated rats. 1992;16:1220-6 De Toni R (see Angeli et al). 1992;16:1389-94 Engel P (see Bastos et al). 1992;16:1434-46 Deulofeu R (see Giménez et al). 1992;16:815-9 Enzan H (see Himeno et al). 1992;16:409-17 Deus J (see Kulisevsky et al). 1992;16:1382-8 Erlinger S. Chronic graft-vs.-host disease of the liver: Another Devaney K, Goodman ZD, Ishak KG. Postinfantile giant-cell indication of ursodeoxycholic acid? 1992;16:1305-7 transformation in hepatitis. 1992;16:327-33 (HEPATOLOGY Elsewhere) Devictor D, Desplanques L, Debray D, Ozier Y, Dubousset Esch O, Spinosa JC, Hamilton RL, Crombie DL, Schteingart A-M, Valayer J, Houssin D, Bernard O, Huault G. CD, Rondinone JF, D’Agostino HB, Lillienau J, Emergency liver transplantation for fulminant liver Hofmann AF. Acute effects of topical methy] tert-butyl failure in infants and children. 1992;16:1156-62 ether or ethyl propionate on gallbladder histology in Dhumeaux D (see Pawlotsky et al). 1992;16:127-31 animals: a comparison of two solvents for contact Dianzani MU (see Parola et al). 1992;16:1014-21 dissolution of cholesterol gallstones. 1992;16:984-91 Di Bisceglie AM, Shindo M, Fong T-L, Fried MW, Swain MG, Estol C (see Lopez et al). 1992;16:162-6 Bergasa NV, Axiotis CA, Waggoner JG, Park Y, Etienne J-P (see Ink et al). 1992;16:912-9 Hoofnagle JH. A pilot study of ribavirin therapy for Eugene C (see Ink et al). 1992;16:912-9 chronic hepatitis C. 1992;16:649-54 Evarts RP (see Hsia et al). 1992;16:1327-33 —— (see Fried et al). 1992;16:861-4 Dick R (see McCormick et al). 1992;16:1180-6 F Dickinson CJ. Hepatitis A— new information on an old virus. 1992;16:1099-1101 (HEPATOLOGY Elsewhere) Fabbri A (see Marchesini et al). 1992;16:149-55 Dickson ER (see Davis et al). 1992;16:1128-36 Fabre M (see Laurent-Puig et al). 1992;16:1171-5 Vol. 16, No. 6, 1992 AUTHOR INDEX Falchetto R (see Bastos et al). 1992;16:1434-46 —— (see Yoshikawa et al). 1992;16:358-64 Fargion S, Piperno A, Cappellini MD, Sampietro M, Fra- Fung JJ (see Demetris et al). 1992;16:671-81 canzani AL, Romano R, Caldarelli R, Marcelli R, Vecchi Furuya T, Murase N, Nakamura K, Woo J, Todo S, Demetris L, Fiorelli G. Hepatitis C virus and porphyria cutanea AJ, Starz] TE. Preformed lymphocytotoxic antibodies: tarda: evidence of a strong association. 1992;16:1322-6 the effects of class, titer and specificity on liver vs. heart —— (see Mandelli et al). 1992;16:956-9 allografts. 1992;16:1415-22 Farrant JM, Doherty DG, Donaldson PT, Vaughan RW, Fusamoto H (see Goto et al). 1992;16:487-93 Hayllar KM, Welsh KI, Eddleston ALWF, Williams R. —— (see Hiramatsu et al). 1992;16:306-11 Amino acid substitutions at position 38 of the DRS —— (see Oshita et al). 1992;16:1007-13 polypeptide confer susceptibility to and protection from —— (see Tanaka et al). 1992;16:479-86 primary sclerosing cholangitis. 1992;16:390-5 Fusconi F (see Barbara et al). 1992;16:132-7 Fattovich G, Giustina G, Brollo L, Guido M, Pontisso P, Fushimi H (see Goto et al). 1992;16:487-93 Noventa F, Alberti A. Therapy for chronic hepatitis B with lymphoblastoid interferon-a and levamisole. 1992; G 16:1115-9 Fernandez CD (see Cascales et al). 1992;16:232-40 Gaal K (see Kamimura et al). 1992;16:448-53 Fernandez-Checa JC (see Hirano et al). 1992;16:1423-7 Gabbiani G (see Rockey et al). 1992;16:776-84 Ferrell L, Wright T, Lake J, Roberts J, Ascher N. Incidence and Gaiani S (see Barbara et al). 1992;16:132-7 diagnostic features of macroregenerative nodules vs. Galand P (see Delhaye et al). 1992;16:382-9 small hepatocellular carcinoma in cirrhotic livers. 1992; Gallati H (see Andus et al). 1992;16:749-55 16:1372-81 Galloway JR (see Henderson et al). 1992;16:715-8 —-—, —-—, Roberts J, Ascher N, Lake J. Hepatitis C viral Garcia-Novo MD (see Ruiz-Moreno et al). 1992;16:882-5 infection in liver transplant recipients. 1992;16:865-76 Garcin H (see Bioulac-Sage et al). 1992;16:418-25 Fevery J (see Gonzalez and Fevery). 1992;16:426-32 Garrido A (see Menéndez et al). 1992;16:931-6 Fiorelli G (see Fargion et al). 1992;16:1322-6 Gasbarrini G (see Andreone et al). 1992;16:550 (Letter) Fischer S (see Berr et al). 1992;16:960-7 —— (see Bernardi et al). 1992;16:341-6 Fitz G. Pumping ions: regulation of intracellular pH in Gatta A (see Angeli et al). 1992;16:1389-94 hepatocytes. 1992;16:271-3 (HEPATOLOGY Elsewhere) Gaudio E (see Riggio et al). 1992;16:785-9 Flejou J-F (see Laurent-Puig et al). 1992;16:1171-5 Gauthier T (see MacIntosh et al). 1992;16:1428-33 Florén C-H (see Liao and Florén). 1992;16:224-31 Gavaler JS, Van Thiel DH. Hormonal status of post- Fong T-L (see Di Bisceglie et al). 1992;16:649-54 menopausal women with alcohol-induced cirrhosis: Fornalé L (see Bernardi et al). 1992;16:341-6 further findings and a review of the literature. 1992;16: Fowler FC, Banks RK, Mailliard ME. Characterization of 312-9 sodium-dependent amino acid transport activity during —— (see Rabinovitz et al). 1992;16:145-8 liver regeneration. 1992;16:1187-94 Gayral F (see Laurent-Puig et al). 1992;16:1171-5 Fracanzani AL (see Fargion et al). 1992;16:1322-6 Gebhardt R. Cell-cell interactions: Clues to hepatocyte hetero- —— (see Mandelli et al). 1992;16:956-9 geneity and beyond? 1992;16:843-5 (HEPATOLOGY Francavilla A, Azzarone A, Carrieri G, Scotti-Foglieni C, Zeng Elsewhere) Q-H, Cillo U, Porter K, Starz] TE. Effect on the canine Gehr P (see Dufour et al). 1992;16:997-1006 Eck fistula liver of intraportal transforming growth Gentilini P (see La Villa et al). 1992;16:156-61 factor-B alone or with hepatic growth factors. 1992;16: Gerbes AL, Witthaut R, Giilberg V, Thibault G, Bilzer M, 1267-70 Jiingst D. Role of the liver in splanchnic extraction of —— (see Guglielmi et al). 1992;16:1144-9 atrial natriuretic factor in the rat. 1992;16:790-3 Franchitto A (see Riggio et al). 1992;16:785-9 —— (see Henriksen et al). 1992;16:1163-70 Franco D (see Laurent-Puig et al). 1992;16:1171-5 Gerok W (see Andus et al). 1992;16:749-55 Frangeul L (see Lunel et al). 1992;16:630-6 Gershwin ME (see Caldwell et al). 1992;16:899-905 Franks JJ (see Kruskal et al). 1992;16:920-3 —— (see Davis et al). 1992;16:1128-36 Frick U (see Berr et al). 1992;16:71-81 Giboudeau J (see Calmus et al). 1992;16:719-23 Fried MW, Korenman JC, Di Bisceglie AM, Park Y, Waggoner Gilles PN, Guerrette DL, Ulevitch RJ, Schreiber RD, Chisari JG, Mitsuya H, Hartman NR, Yarchoan R, Broder S, FV. HBsAg retention sensitizes the hepatocyte to injury Hoofnagle JH. A pilot study of 2’ ,3’-dideoxyinosine for by physiological concentrations of interferon-y. 1992;16: the treatment of chronic hepatitis B. 1992;16:861-4 655-63 —— (see Di Bisceglie et al). 1992;16:649-54 Gillet M (see Bresson-Hadni et al). 1992;16:279-80 (Letter) Friedman SL (see Rockey et al). 1992;16:776-84 Gilmore GT (see Henderson et al). 1992;16:715-8 Fujii T, Kohno M, Hirayama C. Metabolism of !*N-ammonia in Giménez A, Caballeria J, Parés A, Alié S, Deulofeu R, Andreu patients with cirrhosis: a three-compartmental analysis. H, Rodés J. Influence of dietary zinc on hepatic collagen 1992;16:347-52 and prolyl hydroxylase activity in alcoholic rats. 1992; Fujiyoshi M (see Takikawa et al). 1992;16:365-71 16:815-9 Fuke I (see Hiramatsu et al). 1992;16:306-11 —— (see Corrales et al). 1992;16:1922-7 Fukui H (see Goto et al). 1992;16:487-93 Ginés A (see Llach et al). 1992;16:724-7 —— (see Oshita et al). 1992;16:1007-13 Ginés P (see Llach et al). 1992;16:724-7 1518 AUTHOR INDEX HEPATOLOGY Girén JA, Alvarez-Mon M, Menéndez-Caro JL, Abreu L, Gupta S (see Sushma et al). 1992;16:138-44 Albillos A, Manzano L, Durantez A. Increased sponta- —— (see Vemuru et al). 1992;16:968-73 neous and lymphokine-conditioned IgA and IgG syn- thesis by B cells from alcoholic cirrhotic patients. H 1992;16:664-70 —— (see Menéndez et al). 1992;16:931-6 Hacker HJ (see Hagmann et al). 1992;16:1477-84 Giunta A (see Colombo et al). 1992;16:924-30 Hadengue A (see Sogni et al). 1992;16:980-3 Giustina G (see Fattovich et al). 1992;16:1115-9 Hagmann W, Hacker HJ, Buchholz U. Resident mast cells are Goldin RD (see Taylor et al). 1992;16:642-8 the main initiators of anaphylactic leukotriene pro- Gomes MJ (see Bakker et al). 1992;16:404-8 duction in the liver. 1992;16:1477-84 Gémez M (see Landa et al). 1992;16:1474-6 Ham JM (see Henley et al). 1992;16:688-93 Gonzalez AP (see Post et al). 1992;16:803-9 Hamanoue M, Kawaida K, Takao S, Shimazu H, Noji §, Gonzalez J, Fevery J. Spontaneously diabetic biobreeding rats Matsumoto K, Nakamura T. Rapid and marked in- and impairment of bile acid—independent bile flow and duction of hepatocyte growth factor during liver regen- increased biliary bilirubin, calcium and lipid secretion. eration after ischemic or crush injury. 1992;16:1485-92 1992;16:426-32 Hamilton RL (see Esch et al). 1992;16:984-91 Gonzalez P (see Bioulac-Sage et al). 1992;16:418-25 Harada T (see Ito et al). 1992:16:247-54 Gonzalez-Gamarra A (see Solis-Herruzo et al). 1992;16:974-9 Hardison WGM (see Poucell et al). 1992;16:1061-8 Goodman ZD (see Devaney et al). 1992;16:327-33 Hartman GG (see Demetris et al). 1992;16:671-81 Gores GJ (see Sanchez-Urdazpal et al). 1992;16:49-53 Hartman NR (see Fried et al). 1992;16:861-4 —— (see Wiesner et al). 1992;16:1290-9 (Special article) Haruna Y (see Hiramatsu et al). 1992;16:306-11 Goresky CA, Pang KS, Schwab AJ, Barker F III, Cherry WF, Harvey PRC (see Cywes et al). 1992;16:1271-9 Bach GG. Uptake of a protein-bound polar compound, Haussinger D. Nitric oxide and hyperdynamic circulation in acetaminophen sulfate, by perfused rat liver. 1992;16: portal hypertension. 1992;16:1093-4 (HEPATOLOGY 173-90 Elsewhere) —— (see Kassissia et al). 1992;16:763-75 Hay JE (see Wiesner et al). 1992;16:1290-9 (Special article) Gorin FA (see Davis et al). 1992;16:1128-36 Hayakawa T, Katagiri K, Hoshino M, Nakai T, Ohiwa T, Goto M, Takei Y, Kawano S, Tsuji S, Fukui H, Fushimi H, Kumai T, Miyaji M, Takeuchi T, Corasanti J, Boyer JL. Nishimura Y, Kashiwagi T, Fusamoto H, Kamada T. Papaverine inhibits transcytotic vesicle transport and Tumor necrosis factor and endotoxin in the pathogenesis lipid excretion into bile in isolated perfused rat liver. of liver and pulmonary injuries after orthotopic liver 1992;16:1036-42 transplantation in the rat. 1992;16:487-93 Hayashi N (see Hiramatsu et al). 1992;16:306-11 — — (see Oshita et al). 1992;16:1007-13 —— (see Tanaka et al). 1992;16:479-86 Gouillat C (see Bissuel et al). 1992;16:1357-61 Hayllar KM (see Farrant et al). 1992;16:390-5 Govindarajan S (see Ackerman et al). 1992;16:625-9 He D-e (see Sussman et al). 1992;16:60-5 Greenslade L (see McCormick et al). 1992;16:1180-6 Heldwein W (see Beuers et al). 1992;16:707-14 Greig PD (see Cywes et al). 1992;16:1271-9 Henderson JM, Gilmore GT, Mackay GJ, Galloway JR, Dodson Gressner AM, LotfiS, Gressner G, Lahme B. Identification and TF, Kutner MH. Hemodynamics during liver transplan- partial characterization of a hepatocyte-derived factor tation: the interactions between cardiac output and promoting proliferation of cultured fat-storing cells portal venous and hepatic arterial flows. 1992;16:715-8 (parasinusoidal lipocytes). 1992;16:1250-66 Henley KS. Statistics and clinical trials: the case of pred- —— (see Meyer et al). 1992;16:204-16 nisolone in alcoholic hepatitis. 1992;16:1098-9 (HEPA- Gressner G (see Gressner et al). 1992;16:1250-66 TOLOGY Elsewhere) Grigioni W (see Barbara et al). 1992;16:132-7 ——, Lucey MR, Appelman HD, Baliga P, Brown KA, Burtch Grippon P (see Lunel et al). 1992;16:630-6 GD, Campbell DA Jr, Ham JM, Merion RM, Turcotte JG. Groenland TN (see Bakker et al). 1992;16:404-8 Biochemical and histopathological correlation in liver Gross V (see Andus et al). 1992;16:749-55 transplant: the first 180 days. 1992;16:688-93 Groszmann RJ (see Lee et al). 1992;16:1043-8 Henriksen JH, Bendtsen F, Gerbes AL, Christensen NJ, Guechot J (see Calmus et al). 1992;16:719-23 Ring-Larsen H, Sgrensen TIA. Estimated central blood Guerrette DL (see Gilles et al). 1992;16:655-63 volume in cirrhosis: relationship to sympathetic nervous Guglielmi FW, Mastronuzzi T, De Marco M, Laddaga L, activity, B-adrenergic blockade azid atrial natriuretic Panella C, Francavilla A. Oxidative metabolism in factor. 1992;16:1163-70 cirrhotic patients with and without hepatocellular car- Hermans PE (see Paya et al). 1992;16:66-70 cinoma: effects of malnutrition. 1992;16:1144-9 Herrero JI (see Ruiz et al). 1992;16:637-41 Guido M (see Fattovich et al). 1992;16:1115-9 Herve L (see Briand et al). 1992;16:1395-1403 Guirguis S (see Kassissia et al). 1992;16:763-75 Hesselink EJ (see Bakker et al). 1992;16:404-8 Giilberg V (see Gerbes et al). 1992;16:790-3 Higashi Y (see Yoshioka et al). 1992;16:293-9 Gulbis B (see Delhaye et al). 1992;16:382-9 Hijioka T (see Oshita et al). 1992;16:1007-13 Gunji T (see Yoshimi et al). 1992;16:702-6 Himeno H, Saibara T, Onishi S, Yamamoto Y, Enzan H. Giinzler V (see Ala-Kokko et al). 1992;16:167-72 Administration of interleukin-2 induces major histocom- Vol. 16, No. 6, 1992 AUTHOR INDEX patibility complex class II expression on the biliary Imvertarza OC (see Lopez et al). 1992;16:162-6 epithelial cells, possibly through endogenous Inagaki Y (see Adachi et al). 1992;16:1334-7 interferon-y production. 1992;16:409-17 Ink O, Martin T, Poynard T, Reville M, Anciaux M-L, Lenoir Hiraishi H (see Ito et al). 1992;16:247-54 C, Marill J-L, Labadie H, Masliah C, Perrin D, Chaput Hiramatsu N, Hayashi N, Haruna Y, Kasahara A, Fusamoto H, J-C, Vetter D, Eugene C, Lebodic L, Licht H, Etienne Mori C, Fuke I, Okayama H, Kamada T. Immunohis- J-P. Does elective sclerotherapy improve the efficacy of tochemical detection of hepatitis C virus—infected hepa- long-term propranolol for prevention of recurrent tocytes in chronic liver disease with monoclonal anti- bleeding in patients with severe cirrhosis? A prospective bodies to core, envelope and NS3 regions of the hepatitis multicenter randomized trial. 1992;16:912-9 C virus genome. 1992;16:306-11 Inoue S (see Yoshimi et al). 1992;16:702-6 Hirano T, Kaplowitz N, Tsukamoto H, Kamimura §, Ishak KG (see Devaney et al). 1992;16:327-33 Fernandez-Checa JC. Hepatic mitochondrial glu- Ishikawa T (see Yoshioka et al). 1992;16:293-9 tathione depletion and progression of experimental Ishiki Y, Ohnishi H, Muto Y, Matsumoto K, Nakamura T. alcoholic liver disease in rats. 1992;16:1423-7 Direct evidence that hepatocyte growth factor is a Hirayama C (see Fujii et al). 1992;16:347-52 hepatotrophic factor for liver regeneration and has a Hoefs JC. Globulin correction of the albumin gradient: potent antihepatitis effect in vivo. 1992;16:1227-35 correlation with measured serum to ascites colloid Ishimura K (see Kawada et al). 1992;16:462-8 osmotic pressure gradients. 1992;16:396-403 Ishizaka S (see Yoshikawa et al). 1992;16:358-64 Hoek JB (see Ala-Kokko et al). 1992;16:167-72 Ito T (see Tanaka et al). 1992;16:479-86 Hofmann AF (see Esch et al). 1992;16:984-91 Ito Y, Hiraishi H, Razandi M, Terano A, Harada T, Ivey KJ. Holl J (see Berr et al). 1992;16:960-7 Role of cellular superoxide dismutase against reactive Holland PV (see Lee et al). 1992;16:24-30 oxygen metabolite—induced cell damage in cultured rat Holstege A (see Andus et al). 1992;16:749-55 hepatocytes. 1992;16:247-54 Homberg JC (see Abuaf et al). 1992;16:892-8 Itoh Y (see Yoshioka et al). 1992;16:293-9 Homberg J-C (see Lunel et al). 1992;16:630-6 Ivey KJ (see Ito et al). 1992;16:247-54 Honda H (see Utsunomiya et al). 1992;16:694-701 Iwaki Y (see Demetris et al). 1992;16:671-81 Hoofnagle JH (see Di Bisceglie et al). 1992;16:649-54 Iwano K (see Mitsui et al). 1992;16:1109-14 —— (see Fried et al). 1992;16:861-4 Iwatsuki S (see Demetris et al). 1992;16:671-81 Hopf U (see Konig et al). 1992;16:1137-43 —— (see Nonami et al). 1992;16:1195-8 Hornstein B, Stammler L, Bianchi L, Landmann L. Ethi- Izumi N (see Uchihara et al). 1992;16:95-9 nylestradiol increases volume and decreases sinusoidal membrane surface in the rat liver: a stereological J analysis. 1992;16:217-23 Hoshino M (see Hayakawa et al). 1992;16:1036-42 Jain S (see Sushma et al). 1992;16:138-44 Houssin D (see Devictor et al). 1992;16:1156-62 Jansen JBMJ (see Jebbink et al). 1992;16:937-42 Hsia CC, Evarts RP, Nakatsukasa H, Marsden ER, Thor- Jarnagin WR (see Rockey et al). 1992;16:776-84 geirsson SS. Occurrence of oval-type cells in hepatitis B Jebbink MCW, Masclee ADM, van der Kleij FGH, Schipper 4J, virus—associated human hepatocarcinogenesis. 1992;16: Rovati LC, Jansen JBMJ, Lamers CBHW. Effect of 1327-33 loxiglumide and atropine on erythromycin-induced re- Hu W-L, Chindemi PA, Regoeczi E. The perfused liver is duction in gallbladder volume in human subjects. 1992; capable of producing all transferrin glycan variants 16:937-42 found in the sera of intact rats. 1992;16:1049-54 Jeffers LJ (see Caldwell et al). 1992;16:899-905 Huang T-J, Roy Chowdhury J, Lahiri P, Yerneni PC, Bom- Jeffrey AM (see Price et al). 1992;16:8-12 mineni VR, Arias IM, Roy Chowdhury N. Prenatal Johanet C (see Abuaf et al). 1992;16:892-8 diagnosis of bilirubin-UDP-glucuronosyltransferase de- Jiingst D (see Berr et al). 1992;16:960-7 ficiency in rats by genomic DNA analysis. 1992;16: —— (see Gerbes et al). 1992;16:790-3 756-62 Junqué C (see Kulisevsky et al). 1992;16:1382-8 Huault G (see Devictor et al). 1992;16:1156-62 Jwo S-C, Chiu J-H, Chau G-Y, Loong C-C, Lui W-Y. Risk Hultcrantz R (see Lindblad et al). 1992;16:372-81 factors linked to tumor recurrence of human hepatocel- Huraux J-M (see Lunel et al). 1992;16:630-6 lular carcinoma after hepatic resection. 1992;16:1367-71 I K Ikeda N (see Motohashi et al). 1992;16:118-26 Kajikazawa N (see Nomoto et al). 1992;16:1199-1205 Ikeda T, Yanaga K, Kishikawa K, Kakizoe S, Shimada M, Kakizoe S (see Ikeda et al). 1992;16:454-61 Sugimachi K. Ischemic injury in liver transplantation: Kakumu S (see Yoshioka et al). 1992;16:293-9 difference in injury sites between warm and cold Kaler EW (see Kestell et al). 1992;16:1315-21 ischemia in rats. 1992;16:454-61 Kamada T (see Goto et al). 1992;16:487-93 Ilstrup DM (see Paya et al). 1992;16:66-70 —— (see Hiramatsu et al). 1992;16:306-11 Imawari M (see Yoshimi et al). 1992;16:702-6 —— (see Oshita et al). 1992;16:1007-13 1520 AUTHOR INDEX HEPATOLOGY —— (see Tanaka et al). 1992;16:479-86 Kolars JC. Aflatoxin and hepatocellular carcinoma: a useful Kamimura §, Gaal K, Britton RS, Bacon BR, Triadafilopoulos paradigm for environmentally induced carcinogenesis. G, Tsukamoto H. Increased 4-hydroxynonenal levels in 1992;16:848-51 (HEPATOLOGY Elsewhere) experimental alcoholic liver disease: association of lipid Komatsu Y (see Shiratori et al). 1992;16:469-78 peroxidation with liver fibrogenesis. 1992;16:448-53 K6énig V, Bauditz J, Lobeck H, Liisebrink R, Neuhaus P, —— (see Castillo et al). 1992;16:992-6 Blumhardt G, Bechstein WO, Neuhaus R, Steffen R, —— (see Hirano et al). 1992;16:1423-7 Hopf U. Hepatitis C virus reinfection in allografts after Kaneko A (see Tanaka et al). 1992;16:479-86 orthotopic liver transplantation. 1992;16:1137-43 Kaneko S (see Adachi et al). 1992;16:1334-7 Koop DR (see Castillo et al). 1992;16:992-6 —— (see Motohashi et al). 1992;16:118-26 Korenman JC (see Fried et al). 1992;16:861-4 Kaplan M (see Davis et al). 1992;16:1128-36 Kosuge T (see Takayasu et al). 1992;16:906-11 Kaplowitz N (see Hirano et al). 1992;16:1423-7 Kothary PC (see Raper et al). 1992;16:433-9 Karayiannis P (see Taylor et al). 1992;16:642-8 Koussayer T (see Sussman et al). 1992;16:60-5 Kasahara A (see Hiramatsu et al). 1992;16:306-11 Kowalski-Saunders PWJ, Winwood PJ, Arthur MJP, Wright Kashiwagi T (see Goto et al). 1992;16:487-93 R. Reversible inhibition of albumin production by rat —— (see Oshita et al). 1992;16:1007-13 hepatocytes maintained on a _ laminin-rich gel Kassissia I, Rose CP, Goresky CA, Schwab AJ, Bach GG, (Engelbreth-Holm-Swarm) in response to secretory Guirguis S. Flow-limited tracer oxygen distribution in products of Kupffer cells and cytokines. 1992;16:733-41 the isolated perfused rat liver: effects of temperature and Kowdley KV, Tavill AS. An “‘ironic”’ case of mistaken identity. hematocrit. 1992;16:763-75 1992;16:500-1 (Hepatology Elsewhere) Katagiri K (see Hayakawa et al). 1992;16:1036-42 Krawitt E (see Davis et al). 1992;16:1128-36 Katsiyiannakis L (see Sallie et al). 1992;16:1206-11 Krom RAF (see Paya et al). 1992;16:66-70 Katyal SL (see Masuhara et al). 1992;16:1241-9 —— (see Sanchez-Urdazpal et al). 1992;16:49-53 Kawada N, Ueda N, Mizoguchi Y, Kobayashi K, Monna T, —— (see Wiesner et al). 1992;16:1290-9 (Special article) Morisawa S, Ishimura K, Suzuki T, Yamamoto S. Kruis W (see Beuers et al). 1992;16:707-14 Increased 5-lipoxygenase activity in massive hepatic cell Krull N (see Meyer et al). 1992;16:204-16 necrosis in the rat correlates with neutrophil infiltration. Kruskal JB, Robson SC, Franks JJ, Kirsch RE. Elevated 1992;16:462-8 fibrin-related and fibrinogen-related antigens in patients Kawaida K (see Hamanoue et al). 1992;16:1485-92 with liver disease. 1992;16:920-3 Kawano N (see Yoshimi et al). 1992;16:702-6 Kubo R (see Yoshikawa et al). 1992;16:358-64 Kawano S (see Goto et al). 1992;16:487-93 Kuiper J (see Otter et al). 1992;16:54-9 — — (see Oshita et al). 1992;16:1007-13 Kulisevsky J, Pujol J, Balanz6 J, Junqué C, Deus J, Capdevilla Kawase T (see Shiratori et al). 1992;16:469-78 A, Villanueva C. Pallidal hyperintensity on magnetic Kelley A (see Mason et al). 1992;16:36-41 resonance imaging in cirrhotic patients: clinical correla- Kelly JH (see Sussman et al). 1992;16:60-5 tions. 1992;16:1382-8 Kelly RH (see Rabinovitz et al). 1992;16:145-8 Kumai T (see Hayakawa et al). 1992;16:1036-42 Kestell MF, Sekijima J, Lee SP, Park HZ, Long M, Kaler EW. Kutner MH (see Henderson et al). 1992;16:715-8 A calcium binding protein in bile and gallstones. 1992; 16:1315-21 L Kida T, Nakanuma Y, Terada T. Cystic dilatation of peribiliary glands in livers with adult polycystic disease and livers Labadie H (see Ink et al). 1992;16:912-9 with solitary nonparasitic cysts: an autopsy study. Laddaga L (see Guglielmi et al). 1992;16:1144-9 1992;16:334-40 Laffi G (see La Villa et al). 1992;16:156-61 Kim S-K, Belzer FO, Southard JH. Loss of mitochondrial Lahiri P (see Huang et al). 1992;16:756-62 respiratory function and its suppression during cold Lahme B (see Gressner et al). 1992;16:1250-66 ischemic preservation of rat livers with University of Lahoti D (see Sarin et al). 1992;16:1343-9 Wisconsin solution. 1992;16:742-8 Lake J (see Ferrell et al). 1992;16:865-76 Kirsch RE (see Kruskal et al). 1992;16:920-3 Lake JR (see Lidofsky et al). 1992;16:1-7 Kishikawa K (see Ikeda et al). 1992;16:454-61 — — (see Ferrell et al). 1992;16:1372-81 Kiyosawa K (see Nakatsuji et al). 1992;16:300-5 Lamers CBHW (see Jebbink et al). 1992;16:937-42 Kleber G (see Soubrane et al). 1992;16:1447-51 Landa I, Arias J, Gomez M, Quadros M, Moreno A, Balibrea JL. Klein A (see Tur-Kaspa et al). 1992;16:1338-42 Cytoprotective effect of somatostatin in a rat model of Klintmalm GBG (see Paulsen and Klintmalm). 1992;16:100-11 hepatic ischemic reperfusion. 1992;16:1474-6 Knittel T (see Schwégler et al). 1992;16:794-802 Landmann L (see Hornstein et al). 1992;16:217-23 Knot EAR (see Bakker et al). 1992;16:404-8 Langley P (see Panos et al). 1992;16:82-8 Kobayashi K (see Adachi et al). 1992;16:1334-7 Langnas AN, Sorrell MF, Donovan JP, Shaw BW Jr. Surgical —— (see Kawada et al). 1992;16:462-8 management of the Budd-Chiari syndrome: no place for Kohno M (see Fujii et al). 1992;16:347-52 a procrustean bed. 1992;16:1303-5 (HEPATOLOGY Kojima M (see Yotsumoto et al). 1992;16:31-5 Eisewhere) Vol. 16, No. 6, 1992 AUTHOR INDEX 1521 —— (see Donovan et al). 1992;16:267-8 (Editorial) Lopez OL, Estol C, Colina I, Quiroga J, Imvertarza OC, van Laperche S (see Abuaf et al). 1992;16:892-8 Thiel DH. Neurological complications after liver retrans- Larson-Keller JJ (see Paya et al). 1992;16:66-70 plantation. 1992;16:162-6 LaRusso NF (see Wiesner et al). 1992;16:1290-9 (Special Lotfi S (see Gressner et al). 1992;16:1250-66 article) Lu S-N (see Chen et al). 1992;16:1150-5 Laskin DL (see McCloskey et al). 1992;16:191-203 Lucey MR (see Henley et al). 1992;16:688-93 Laskus T (see Cianciara and Laskus). 1992;16:1507-8 (Letter) Ludwig J (see Paya et al). 1992;16:66-70 Laurent-Puig P, Flejou J-F, Fabre M, Bedossa P, Belghiti J, Lui W-Y (see Jwo et al). 1992;16:1367-71 Gayral F, Franco D. Overexpression of p53: a rare event Lunec J (see Challen et al). 1992;16:1362-6 in a large series of white patients with hepatocellular Lunel F, AbuafN , Frangeul L, Grippon P, Perrin M, Le Coz Y, carcinoma. 1992;16:1171-5 Valla D, Borotto E, Yamamoto A-M, Huraux J-M, La Villa G, Romanelli RG, Raggi VC, Tosti-Guerra C, De Feo Opolon P, Homberg J-C. Liver/kidney microsome an- ML, Marra F, Laffi G, Gentilini P. Plasma levels of brain tibody type 1 and hepatitis C virus infection. 1992;16: natriuretic peptide in patients with cirrhosis. 1992;16: 630-6 156-61 Liisebrink R (see K6nig et al). 1992;16:1137-43 Lebodic L (see Ink et al). 1992;16:912-9 Lebrec D (see Sogni et al). 1992;16:980-3 M —— (see Soubrane et al). 1992;16:1447-51 Le Coz Y (see Lunel et al). 1992;16:630-6 Machida A, Ohnuma H, Tsuda F, Munekata E, Tanaka T, Lee F-Y, Albillos A, Colombato LA, Groszmann RJ. The role of Akahane Y, Okamoto H, Mishiro S. Two distinct sub- nitric oxide in the vascular hyporesponsiveness to types of hepatitis C virus defined by antibodies directed methoxamine in portal hypertensive rats. 1992;16: to the putative core protein. 1992;16:886-91 1043-8 MacIntosh E, Gauthier T, Pettigrew N, Minuk G. Liver Lee J-H, Paglieroni TG, Holland PV, Zeldis JB. Chronic regeneration and the effect of exogenous putrescine on hepatitis B virus infection in an anti-HBc—nonreactive regenerative activity after partial hepatectomy in cir- blood donor: Variant virus or defective immune re- rhotic rats. 1992;16:1428-33 sponse? 1992;16:24-30 Mackay GJ (see Henderson et al). 1992;16:715-8 Lee S-D (see Wu et al). 1992;16:1120-7 Mackay IR (see Caldwell et al). 1992;16:899-905 Lee SP (see Kestell et al). 1992;16:1315-21 Maggiore G, De Giacomo C. Efficacy of ursodeoxycholic acid in Lenoir C (see Ink et al). 1992;16:912-9 preventing cholestatic episodes in a patient with benign Lenys D (see Bresson-Hadni et al). 1992;16:279-80 (Letter) recurrent intrahepatic cholestasis. 1992;16:504 (Letter) Leonarduzzi G (see Parola et al). 1992;16:1014-21 Maher JJ (see Rockey et al). 1992;16:776-84 Leung P (see Davis et al). 1992;16:1128-36 Mailliard ME (see Fowler et al). 1992;16:1187-94 Leung PSC (see Caldwell et al). 1992;16:899-905 Mainolfi E (see Adams et al). 1992;16:810-4 Levine BA (see Zhou et al). 1992;16:1236-40 Mairesse N (see Delhaye et al). 1992;16:382-9 Liao W, Florén C-H. Endotoxins inhibit endocytotic catabolism Makuuchi M (see Takayasu et al). 1992;16:906-11 of low-density lipoproteins in Hep G2 cells. 1992;16: Makwana UK (see Sarin et al). 1992;16:1343-9 224-31 Mandelli C, Cesarini L, Piperno A, Fargion S, Fracanzani AL, Licht H (see Ink et al). 1992;16:912-9 Barisani D, Conte D. Saturability of hepatic iron deposits Lidofsky SD, Bass NM, Prager MC, Washington DE, Read AE, in genetic hemochromatosis. 1992;16:956-9 Wright TL, Ascher NL, Roberts JP, Scharschmidt BF, Manez R (see Demetris et al). 1992;16:671-81 Lake JR. Intracranial pressure monitoring and liver Manns M (see Davis et al). 1992;16:1128-36 transplantation for fulminant hepatic failure. 1992; Mantion G (see Bresson-Hadni et al). 1992;16:279-80 (Letter) 16:1-7 Manzano L (see Girén et al). 1992;16:664-70 Ligabue A (see Bernardi et al). 1992;16:341-6 —— (see Menéndez et al). 1992;16:931-6 Lillienau J (see Esch et al). 1992;16:984-91 Marcelli R (see Fargion et al). 1992;16:1322-6 Lin H-C (see Soubrane et al). 1992;16:1447-51 Marchesini G, Bugianesi E, Bianchi G, Fabbri A, Marchi E, Zoli Lin H-M (see Chou et al). 1992;16:13-8 M, Pisi E. Defective methionine metabolism in cirrhosis: Lindblad A, Hultcrantz R, Strandvik B. Bile-duct destruction relation to severity of liver disease. 1992;16:149-55 and collagen deposition: a prominent ultrastructural Marchi E (see Marchesini et al). 1992;16:149-55 feature of the liver in cystic fibrosis. 1992;16:372-81 Marill J-L (see Ink et al). 1992;16:912-9 Llach J, Rimola A, Navasa M, Ginés P, Salmerén JM, Ginés A, Marin MG (see Puoti et al). 1992;16:877-81 Arroyo V, Rodés J. Incidence and predictive factors of Marra F (see La Villa et al). 1992;16:156-61 first episode of spontaneous bacterial peritonitis in Marsden ER (see Hsia et al). 1992;16:1327-33 cirrhosis with ascites: relevance of ascitic fluid protein Marsh DC (see Vreugdenhil et al). 1992;16:241-6 concentration. 1992;16:724-7 Martin P, Friedman L. Hepatitis C: evaluating the seropositive Lobeck H (see Kénig et al). 1992;16:1137-43 blood donor (1992;15:967-9). 1992;16:501 (Correction) Long M (see Kestell et al). 1992;16:1315-21 Martin-Sanz P (see Cascales et al). 1992;16:232-40 Loong C-C (see Jwo et al). 1992;16:1367-71 Martin T (see Ink et al). 1992;16:912-9 1522 AUTHOR INDEX HEPATOLOGY Martini E (see Abuaf et al). 1992;16:892-8 Meyer zum Biischenfelde K-H (see Schwégler et al). 1992;16: Marumo F (see Uchihara et al). 1992;16:95-9 794-802 Masclee ADM (see Jebbink et al). 1992;16:937-42 Mieli-Vergani G (see Sallie et al). 1992;16:1206-11 Masliah C (see Ink et al). 1992;16:912-9 Miguet J-P (see Bresson-Hadni et al). 1992;16:279-80 (Letter) Mason A, Yoffe B, Noonan C, Mearns M, Campbell C, Kelley Mikami M (see Mitaka et al). 1992;16:440-7 A, Perrillo RP. Hepatitis B virus DNA in peripheral- Miller C (see Theise et al). 1992;16:949-55 blood mononuclear cells in chronic hepatitis B after Minagawa H (see Tanaka et al). 1992;16:1409-14 HBsAg clearance. 1992;16:36-41 Minamishima Y (see Tanaka et al). 1992;16:1409-14 Mastronuzzi T (see Guglielmi et al). 1992;16:1144-9 Minuk G (see MacIntosh et al). 1992;16:1428-33 Masuhara M, Katyal SL, Nakamura T, Shinozuka H. Differ- Mishiro S (see Machida et al). 1992;16:886-91 ential expression of hepatocyte growth factor, trans- —— (see Mitsui et al). 1992;16:1109-14 forming growth factor-a and transforming growth —— (see Okada et al). 1992;16:619-24 factor-B, messenger RNAs in two experimental models —— (see Yotsumoto et al). 1992;16:31-5 of liver cell proliferation. 1992;16:1241-9 Mitaka T, Mikami M, Sattler GL, Pitot HC, Mochizuki Y. Small Masuko K (see Mitsui et al). 1992;16:1109-14 cell colonies appear in the primary culture of adult rat Mato JM (see Corrales et al). 1992;16:1922-7 hepatocytes in the presence of nicotinamide and epi- Matsumata T (see Utsunomiya et al). 1992;16:694-701 dermal growth factor. 1992;16:440-7 Matsumoto A (see Nakatsuji et al). 1992;16:300-5 Mitsui T, Iwano K, Masuko K, Yamazaki C, Okamoto H, Tsuda Matsumoto K (see Hamanoue et al). 1992;16:1485-92 F, Tanaka T, Mishiro S. Hepatitis C virus infection in —— (see Ishiki et al). 1992;16:1227-35 medical personnel after needlestick accident. 1992;16: Matsumura K (see Yoshikawa et al). 1992;16:358-64 1109-14 Matsumura Y (see Yoshikawa et al). 1992;16:358-64 Mitsuya H (see Fried et al). 1992;16:861-4 Matsunaga T (see Oshita et al). 1992;16:1007-13 Miyai K (see Poucell et al). 1992;16:1061-8 Matsushita E (see Adachi et al). 1992;16:1334-7 Miyaji M (see Hayakawa et al). 1992;16:1036-42 Maus TP (see Sanchez-Urdazpal et al). 1992;16:49-53 Miyoshi E (see Tanaka et al). 1992;16:479-86 Mazziotti A (see Barbara et al). 1992;16:132-7 Mizoguchi Y (see Kawada et al). 1992;16:462-8 McCloskey TW, Todaro JA, Laskin DL. Lipopolysaccharide Mochizuki Y (see Mitaka et al). 1992;16:440-7 treatment of rats alters antigen expression and oxidative Moncada S (see Whittle and Moncada). 1992;16:1089-92 metabolism in hepatic macrophages and endothelial (Editorial) cells. 1992;16:191-203 Monna T (see Kawada et al). 1992;16:462-8 McCollum MO (see Zhou et al). 1992;16:1236-40 Moore SB (see Paya et al). 1992;16:66-70 McCormick PA, Biagini MR, Dick R, Greenslade L, Chin J, —— (see Sanchez-Urdazpal et al). 1992;16:49-53 Cardin F, Wagstaff D, McIntyre N, Burroughs AK. Morali GA, Tobe SW, Skorecki KL, Blendis LM. Refractory Octreotide inhibits the meal-induced increases in the ascites: modulation of atrial natriuretic factor unrespon- portal venous pressure of cirrhotic patients with portal siveness by mannitol. 1992;16:42-8 hypertension: a double-blind, placebo-controlled study. Moreau R (see Sogni et al). 1992;16:980-3 1992;16:1180-6 Moreno A (see Landa et al). 1992;16:1474-6 McHutchison JG (see Ackerman et al). 1992;16:625-9 Moretti R (see Riggio et al). 1992;16:785-9 McIntyre N (see McCormick et al). 1992;16:1180-6 Morgan GR (see Cywes et al). 1992;16:1271-9 Mearns M (see Mason et al). 1992;16:36-41 Morgan TR, Mendenhall CL. Nutritional therapy for alcoholic Mendenhall CL (see Morgan and Mendenhall). 1992;16:845-8 hepatitis: Are we there yet? 1992;16:845-8 (HEPA- (HEPATOLOGY Elsewhere) TOLOGY Elsewhere) Menéndez JL, Girén JA, Manzano L, Garrido A, Abreu L, Mori C (see Hiramatsu et al). 1992;16:306-11 Albillos A, Durantez A, Alvarez-Mon M. Deficient Mori R (see Tanaka et al). 1992;16:1409-14 interleukin-2 responsiveness of T lymphocytes from Morisawa S (see Kawada et al). 1992;16:462-8 patients with primary biliary cirrhosis. 1992;16: Morishima T (see Yoshioka et al). 1992;16:293-9 931-6 Moriyama N (see Takayasu et al). 1992;16:906-11 Menéndez-Caro JL (see Girén et al). 1992;16:664-70 Mortensen PB. The effect of oral-administered lactulose on Menger MD (see Post et al). 1992;16:803-9 colonic nitrogen metabolism and excretion. 1992;16: Menon F (see Angeli et al). 1992;16:1389-94 1350-6 Merion RM (see Henley et al). 1992;16:688-93 Motohashi I, Okudaira M, Takai T, Kaneko S, Ikeda N. Merkel C (see Angeli et al). 1992;16:1389-94 Morphological differences between hepatocellular car- Merli M (see Riggio et al). 1992;16:785-9 cinoma and hepatocellular carcinomalike lesions. 1992; Metreau J-M (see Pawlotsky et al). 1992;16:127-31 16:118-26 Metselaar HJ (see Bakker et al). 1992;16:404-8 Mowat A (see Sallie et al). 1992;16:1206-11 Meyer DH, Krull N, Dreher KL, Gressner AM. Biglycan and Muller S (see Briand et al). 1992;16:1395-1403 decorin gene expression in normal and fibrotic rat liver: Munekata E (see Machida et al). 1992;16:886-91 cellular localization and regulatory factors. 1992;16: Munoz SJ (see Davis et al). 1992;16:1128-36 204-16 Munioz-Yagtie MT (see Solis-Herruzo et al). 1992;16:974-9

ebook img

Hepatology 1992: Vol 16 Index PDF

45 Pages·1992·15 MB·English
by  
#periodicals #sim_microfilm #pub_hepatology
Save to my drive
Quick download
Download
Upgrade Premium
Most books are stored in the elastic cloud where traffic is expensive. For this reason, we have a limit on daily download.

Preview Hepatology 1992: Vol 16 Index

Author Index to Volume 16* A Andreu H (see Corrales et al). 1992;16:1922-7 Abreu L (see Girén et al). 1992;16:664-70 —— (see Giménez et al). 1992;16:815-9 —— (see Menéndez et al). 1992;16:931-6 Andus T, Gross V, Holstege A, Ott M, Weber M, David M, Abuaf N, Johanet C, Chretien P, Martini E, Soulier E, Gallati H, Gerok W, Schélmerich J. High concentrations Laperche S, Homberg JC. Characterization of the liver of soluble tumor necrosis factor receptors in ascites. cytosol antigen type 1 reacting with autoantibodies in 1992;16:749-55 chronic active hepatitis. 1992;16:892-8 Angeli P, Caregaro L, Menon F, Sacerdoti D, De Toni R, Merkel —— (see Lunel et al). 1992;16:630-6 C, Gatta A. Variability of atrial natriuretic peptide Ackerman Z, Valinluck B, McHutchison JG, Redeker AG, plasma levels in ascitic cirrhotic patients: pathophysio- Govindarajan S. Spontaneous exacerbation of disease logical and clinical implications. 1992;16:1389-94 activity in patients with chronic delta hepatitis infection: Angus PW (see Dixon et al). 1992;16:943-8 The role of hepatitis B, C or D? 1992;16:625-9 Annoni G (see Torgano et al). 1992;16:19-23 Acs G (see Price et al). 1992;16:8-12 Aoki K (see Okada et al). 1992;16:112-7 Adachi E (see Utsunomiya et al). 1992;16:694-701 Appelman HD (see Henley et al). 1992;16:688-93 Adachi H, Kaneko S, Matsushita E, Inagaki Y, Unoura M, Aragona E (see Vemuru et al). 1992;16:968-73 Kobayashi K. Clearance of HBsAg in seven patients with Arias IM (see Huang et al). 1992;16:756-62 chronic hepatitis B. 1992;16:1334-7 Arias J (see Landa et al). 1992;16:1474-6 Adams DH, Mainolfi E, Burra P, Neuberger JM, Ayres R, Elias Arnold JC, Portmann BC, O’Grady JG, Naoumov NV, Alex- E, Rothlein R. Detection of circulating intercellular ander GJM, Williams R. Cytomegalovirus infection adhesion molecule-1 in chronic liver diseases. 1992;16: persists in the liver graft in the vanishing bile duct 810-4 syndrome. 1992;16:285-92 Aharonson S (see Tur-Kaspa et al). 1992;16:1338-42 Arosio E (see Torgano et al). 1992;16:19-23 Ahlberg J (see Sahlin et al). 1992;16:320-6 Arroyo V (see Llach et al). 1992;16:724-7 Akahane Y (see Machida et al). 1992;16:886-91 Arthur MJP (see Kowalski-Saunders et al). 1992;16:733-41 —— (see Okada et al). 1992;16:619-24 Asakura H (see Nomoto et al). 1992;16:1199-1205 Ala-Kokko L, Giinzler V, Hoek JB, Rubin E, Prockop DJ. Ascher N (see Ferrell et al). 1992;16:865-76 Hepatic fibrosis in rats produced by carbon tetrachloride Ascher NL (see Lidofsky et al). 1992;16:1-7 and dimethylnitrosamine: observations suggesting im- —— (see Ferrell et al). 1992;16:1372-81 munoassays of serum for the 7S fragment of type IV Askari F, Wilson J. Provocative gene therapy strategy for the collagen are a more sensitive index of liver damage than treatment of hepatocellular carcinoma. 1992;16:273-4 immunoassays for the NH,-terminal propeptide of type (HEPATOLOGY Elsewhere) III procollagen. 1992;16:167-72 Assaisso M (see Colombo et al). 1992;16:924-30 Albano E (see Parola et al). 1992;16:1014-21 Audet R (see Swain et al). 1992;16:1028-35 Alberti A (see Fattovich et al). 1992;16:1115-9 Axiotis CA (see Di Bisceglie et al). 1992;16:649-54 Albillos A (see Girén et al). 1992;16:664-70 Aydemir U (see Beuers et al). 1992;16:707-14 —— (see Lee et al). 1992;16:1043-8 Ayres R (see Adams et al). 1992;16:810-4 —— (see Menéndez et al). 1992;16:931-6 Ayuso C (see Vilana et al). 1992;16:353-7 Alexander GJM (see Arnold et al). 1992;16:285-92 Azzarone A (see Francavilla et al). 1992;16:1267-70 Alié S (see Giménez et al). 1992;16:815-9 Aligué R (see Bastos et al). 1992;16:1434-46 B Alvarez A (see Cascales et al). 1992;16:232-40 Alvarez L (see Corrales et al). 1992;16:1922-7 Bach GG (see Goresky et al). 1992;16:173-90 Alvarez-Mon M (see Girén et al). 1992;16:664-70 —— (see Kassissia et al). 1992;16:763-75 —— (see Menéndez et al). 1992;16:931-6 Bachs O (see Bastos et al). 1992;16:1434-46 Anciaux M-L (see Ink et al). 1992;16:912-9 Back N, Bodenheimer HC Jr. Transmission of hepatitis C: Anderson JV (see Panos et al). 1992;16:82-8 Sexual, vertical or exclusively blood-borne? 1992;16: Andre C (see Briand et al). 1992;16:1395-1403 1497-9 (HEPATOLOGY Elsewhere) —— (see Pawlotsky et al). 1992;16:127-31 Bacon BR (see Kamimura et al). 1992;16:448-53 Andreone P, Cursaro C, Gasbarrini G. Interferon-a therapy Baker JR Jr. The immune response in chronic hepatitis B virus combined with nonsteroid antiinflammatory drugs for infection: The “‘core”’ of the problem? 1992;16:498-500 treatment of chronic viral hepatitis? 1992;16:505 (Hepatology Elsewhere) —— (see Bernardi et al). 1992;16:341-6 Bakker CM, Metselaar HJ, Groenland TN, Gomes MJ, Knot EAR, Hesselink EJ, Schalm SW, Stibbe J, Terpstra OT. Increased tissue-type plasminogen activator activity in *July, 1-284; August, 285-618; September, 619-860; October, 861-1108; orthotopic but not heterotopic liver transplantation: the November, 1109-1314; December, 1315-1510. role of the anhepatic period. 1992;16:404-8 1513 1514 AUTHOR INDEX HEPATOLOGY Balabaud C (see Bioulac-Sage et al). 1992;16:418-25 phospholipid fatty acid species with cholesterol satu- Balanzé J (see Kulisevsky et al). 1992;16:1382-8 ration of duodenal bile in health and gallstone disease. Baldwin D (see Sallie et al). 1992;16:1206-11 1992;16:71-81 Balibrea JL (see Landa et al). 1992;16:1474-6 Beuers U, Spengler U, Kruis W, Aydemir U, Wiebecke B, Baliga P (see Henley et al). 1992;16:688-93 Heldwein W, Weinzierl M, Pape GR, Sauerbruch T, Banerjee R (see Price et al). 1992;16:8-12 Paumgartner G. Ursodeoxycholic acid for treatment of Banks RK (see Fowler et al). 1992;16:1187-94 primary sclerosing cholangitis: a placebo-controlled trial. Baraldini M (see Bernardi et al). 1992;16:341-6 1992;16:707-14 Barbara C (see Barbara et al). 1992;16:132-7 Bhargava DK (see Dasarathy et al). 1992;16:89-94 Barbara L, Benzi G, Gaiani S, Fusconi F, Zironi G, Siringo S, Bhist MS (see Sushma et al). 1992;16:138-44 Rigamonti A, Barbara C, Grigioni W, Mazziotti A, Bhunchet E, Wake K. Role of mesenchymal cell populations in Bolondi L. Natural history of small untreated hepato- porcine serum-—induced rat liver fibrosis. 1992;16: cellular carcinoma in cirrhosis: a multivariate analysis of 1452-73 prognostic factors of tumor growth rate and patient Biagini MR (see McCormick et al). 1992;16:1180-6 survival. 1992;16:132-7 Bianchi G (see Marchesini et al). 1992;16:149-55 Barisani D (see Mandelli et al). 1992;16:956-9 Bianchi L (see Hornstein et al). 1992;16:217-23 Barker F III (see Goresky et al). 1992;16:173-90 Biasi F (see Parola et al). 1992;16:1014-21 Barnett JL. Cholangitis and endoscopic drainage. 1992;16: Bilzer M (see Gerbes et al). 1992;16:790-3 1302-3 (HEPATOLOGY Elsewhere) Biocca ME (see Parola et al). 1992;16:1014-21 Barrett-Bergshoeff MM (see Otter et al). 1992;16:54-9 Bioulac-Sage P, Dubuisson L, Bedin C, Gonzalez P, de Tinguy- Bartula L (see Myers and Bartula). 1992;16:1176-9 Moreaud E, Garcin H, Balabaud C. Nodular regenerative Bass NM (see Lidofsky et al). 1992;16:1-7 hyperplasia in the rat induced by a selenium-enriched Bassendine MF (see Challen et al). 1992;16:1362-6 diet: study of a model. 1992;16:418-25 Bastos R, Engel P, Pujades C, Falchetto R, Aligué R, Bachs O. Bissuel F, Bizollon T, Dijoud F, Bouletreau P, Cordier JF, Increase of cytokeratin D during liver regeneration: Chazot C, Gouillat C, Trepo C. Pulmonary hemorrhage association with the nuclear matrix. 1992;16:1434-46 and glomerulonephritis in primary biliary cirrhosis. Battezzati PM (see Colombo et al). 1992;16:924-30 1992;16:1357-61 Bauditz J (see Kénig et al). 1992;16:1137-43 Bizollon T (see Bissuel et al). 1992;16:1357-61 Beaugrand M (see Pawlotsky et al). 1992;16:127-31 Blei AT (see Coy et al). 1992;16:278-9 (Letter) Bechstein WO (see Kénig et al). 1992;16:1137-43 —— (see Swain et al). 1992;16:1028-35 Becker M-C (see Bresson-Hadni et al). 1992;16:279-80 (Letter) Blendis LM. Hepatology Elsewhere: twenty years after! 1992; Bedin C (see Bioulac-Sage et al). 1992;16:418-25 16:1096-8 (HEPATOLOGY Elsewhere) Bedossa P (see Laurent-Puig et al). 1992;16:1171-5 —— (see Morali et al). 1992;16:42-8 Belghiti J (see Laurent-Puig et al). 1992;16:1171-5 Blumhardt G (see Konig et al). 1992;16:1137-43 Beloqui O (see Ruiz et al). 1992;16:637-41 Bodenheimer HC Jr (see Back and Bodenheimer). 1992;16: Belzer FO (see Kim et al). 1992;16:742-8 1497-9 (HEPATOLOGY Elsewhere) —— (see Vreugdenhil et al). 1992;16:241-6 Bolondi L (see Barbara et al). 1992;16:132-7 Bendtsen F (see Henriksen et al). 1992;16:1163-70 Bommineni VR (see Huang et al). 1992;16:756-62 Benzi G (see Barbara et al). 1992;16:132-7 Bonnefis M-T (see Calmus et al). 1992;16:719-23 Bergasa NV (see Di Bisceglie et al). 1992;16:649-54 Borotto E (see Lunel et al). 1992;16:630-6 Bergeron M (see Swain et al). 1992;16:1028-35 Bosca L (see Cascales et al). 1992;16:232-40 Berk PD. Guidelines for training in hepatology. 1992;16: Bouletreau P (see Bissuel et al). 1992;16:1357-61 1084-6 (Special article) Boyer JL (see Hayakawa et al). 1992;16:1036-42 — —. Redundant publication: déja vu all over again. 1992;16: Braillon A (see Soubrane et al). 1992;16:1447-51 840-2 (Editorial) Bray G (see Underhill et al). 1992;16:1404-8 — — (see Schiff et al). 1992;16:1087-8 (Editorial) Bresson-Hadni S, Miguet J-P, Lenys D, Vuitton D-A, Viennet Berkowitz CM. Does albumin regulate albumin? 1992;16: G, Becker M-C, Rohmer P, Mantion G, Gillet M. 1499-501 (HEPATOLOGY Elsewhere) Recurrence of alveolar echinococcosis in the liver graft Bernard O (see Devictor et al). 1992;16:1156-62 after liver transplantation. 1992;16:279-80 (Letter) Bernardi M, Di Marco C, Trevisani F, De Collibus C, Fornalé Briand J-P, Andre C, Tuaillon N, Herve L, Neimark J, Muller L, Baraldini M, Andreone P, Cursaro C, Zaca F, Ligabue S. Multiple autoepitope presentation for specific de- A, Gasbarrini G. The hemodynamic status of preascitic tection of antibodies in primary biliary cirrhosis. 1992; cirrhosis: an evaluation under steady-state conditions 16:1395-1403 and after postural change. 1992;16:341-6 Britton RS (see Kamimura et al). 1992;16:448-53 Berr F, Holl J, Jiingst D, Fischer S, Richter WO, Seifferth B, Broder S (see Fried et al). 1992;16:861-4 Paumgartner G. Dietary N-3 polyunsaturated fatty acids Brollo L (see Fattovich et al). 1992;16:1115-9 decrease biliary cholesterol saturation in gallstone Bronsther O (see Demetris et al). 1992;16:671-81 disease. 1992;16:960-7 Brown KA (see Henley et al). 1992;16:688-93 — —, Schreiber E, Frick U. Interrelationships of bile acid and Bru C (see Vilana et al). 1992;16:353-7 Vol. 16, No. 6, 1992 AUTHOR INDEX Bruix J (see Vilana et al). 1992;16:353-7 Chazot C (see Bissuel et al). 1992;16:1357-61 Buchholz U (see Hagmann et al). 1992;16:1477-84 Chen C-J, Zhang Y-J, Lu S-N, Santella RM. Aflatoxin B, DNA Bugianesi E (see Marchesini et al). 1992;16:149-55 adducts in smeared tumor tissue from patients with Burra P (see Adams et al). 1992;16:810-4 hepatocellular carcinoma. 1992;16:1150-5 Burroughs AK (see McCormick et al). 1992;16:1180-6 Chen C-L (see Wu et al). 1992;16:1120-7 Burtch GD (see Henley et al). 1992;16:688-93 Cherry WF (see Goresky et al). 1992;16:173-90 Butterworth RF (see Swain et al). 1992;16:1028-35 Chi C-W (see Chou et al). 1992;16:13-8 Chin J (see McCormick et al). 1992;16:1180-6 Chindemi PA (see Hu et al). 1992;16:1049-54 Cc Chisari FV (see Gilles et al). 1992;16:655-63 Caballeria J (see Corrales et al). 1992;16:1922-7 Chiu J-H (see Jwo et al). 1992;16:1367-71 —— (see Giménez et al). 1992;16:815-9 Chong MG (see Sussman et al). 1992;16:60-5 Cailmail S (see Sogni et al). 1992;16:980-3 Chou C-K, Wang L-H, Lin H-M, Chi C-W. Glucocorticoid Caldarelli R (see Fargion et al). 1992;16:1322-6 stimulates hepatitis B viral gene expression in cultured Caldwell SH, Leung PSC, Spivey JR, Prindiville T, de Medina human hepatoma cells. 1992;16:13-8 M, Saicheur T, Rowley M, Reddy KR, Coppel R, Jeffers Chretien P (see Abuaf et al). 1992;16:892-8 LJ, Mackay IR, Schiff ER, Gershwin ME. Antimitochon- Christensen NJ (see Henriksen et al). 1992;16:1163-70 drial antibodies in kindreds of patients with primary Cianciara J, Laskus T. Thymic factor X treatment of chronic biliary cirrhosis: antimitochondrial antibodies are hepatitis B. 1992;16:1507-8 (Letter) unique to clinical disease and are absent in asymp- Cillo U (see Francavilla et al). 1992;16:1267-70 tomatic family members. 1992;16:899-905 Clavien P-A (see Cywes et al). 1992;16:1271-9 Calmus Y, Guechot J, Podevin P, Bonnefis M-T, Giboudeau J, —— (see Strasberg and Clavien). 1992;16:820-39 (Special Poupon R. Differential effects of chenodeoxycholic and article) ursodeoxycholic acids on interleukin-1, interleukin-6 Coates PJ (see Palmer et al). 1992;16:682-7 and tumor necrosis factor-a production by monocytes. Colina I (see Lopez et al). 1992;16:162-6 1992;16:719-23 Collier J (see Challen et al). 1992;16:1362-6 Campbell C (see Mason et al). 1992;16:36-41 Colombato LA (see Lee et al). 1992;16:1043-8 Campbell DA Jr (see Henley et al). 1992;16:688-93 Colombo C, Crosignani A, Assaisso M, Battezzati PM, Podda Cantafora A (see Riggio et al). 1992;16:785-9 M, Giunta A, Zimmer-Nechemias L, Setchell KDR. Urso- Capdevilla A (see Kulisevsky et al). 1992;16:1382-8 deoxycholic acid therapy in cystic fibrosis—associated Capocaccia L (see Riggio et al). 1992;16:785-9 liver disease: a dose-response study. 1992;16:924-30 Cappellini MD (see Fargion et al). 1992;16:1322-6 Conte D (see Mandelli et al). 1992;16:956-9 Carbone D. The P53 “knockout”: gone but not forgotten. Contessini E (see Torgano et al). 1992;16:19-23 1992;16:1094-6 (HEPATOLOGY Elsewhere) Coppel R (see Caldwell et al). 1992;16:899-905 Cardin F (see McCormick et al). 1992;16:1180-6 —— (see Davis et al). 1992;16:1128-36 Caregaro L (see Angeli et al). 1992;16:1389-94 Corasanti J (see Hayakawa et al). 1992;16:1036-42 Cariani E (see Puoti et al). 1992;16:877-81 Cordier JF (see Bissuel et al). 1992;16:1357-61 Carreno V (see Ruiz-Moreno et al). 1992;16:882-5 Corrales F, Giménez A, Alvarez L, Caballeria J, Pajares MA, Carrieri G (see Francavilla et al). 1992;16:1267-70 Andreu H, Parés A, Mato JM, Rodés J. Cascales M, Martin-Sanz P, Alvarez A, Sanchez-Pérez M, S-adenosylmethionine treatment prevents carbon Fernandez CD, Bosca L. Isoenzymes of carbohydrate tetrachloride—-induced S-adenosylmethionine syn- metabolism in primary cultures of hepatocytes from thetase inactivation and attenuates liver injury. 1992; thicacetamide-induced rat liver necrosis: responses to 16:1922-7 growth factors. 1992;16:232-40 Cote P (see Diehl et al). 1992;16:1212-9 Caschera M (see Riggio et al). 1992;16:785-9 Coy DL, Zee P, Blei AT. Quantitating hepatic encephalopathy Castellano G (see Solis-Herruzo et al). 1992;16:974-9 in rats after portacaval anastomosis. 1992;16:278-9 Castelnuovo F (see Puoti et al). 1992;16:877-81 (Letter) Castillo I (see Ruiz-Moreno et al). 1992;16:882-5 Crabb DW. ADH1, 2 and 3: genes whose times have come. Castillo T, Koop DR, Kamimura S, Triadafilopoulos G, 1992;16:1501-3 (HEPATOLOGY Elsewhere) Tsukamoto H. Role of cytochrome P-450 2E1 in Crombie DL (see Esch et al). 1992;16:984-91 ethanol-, carbon tetrachloride— and iron-dependent mi- Crosignani A (see Colombo et al). 1992;16:924-30 crosomal lipid peroxidation. 1992;16:992-6 Crowther RS (see Qiu et al). 1992;16:1280-9 Ceneviva R (see Roselino et al). 1992;16:1055-60 Cuende JI (see Ruiz et al). 1992;16:637-41 Cesarini L (see Mandelli et al). 1992;16:956-9 Cursaro C (see Andreone et al). 1992;16:550 (Letter) Challen C, Lunec J, Warren W, Collier J, Bassendine MF. —— (see Bernardi et al). 1992;16:341-6 Analysis of the p53 tumor-suppressor gene in hepatocel- Cywes R, Greig PD, Morgan GR, Sanabria JR, Clavien P-A, lular carcinomas from Britain. 1992;16:1362-6 Harvey PRC, Strasberg SM. Rapid donor liver nutri- Chaput J-C (see Ink et al). 1992;16:912-9 tional enhancement in a large animal model. 1992;16: Chau G-Y (see Jwo et al). 1992;16:1367-71 1271-9 AUTHOR INDEX HEPATOLOGY D —— (see Wiesner et al). 1992;16:1290-9 (Special article) D’ Agostino HB (see Esch et al). 1992;16:984-91 Diehl AM, Yang SQ, Cote P, Wand GS. Chronic ethanol D’Aquilino E (see Riggio et al). 1992;16:785-9 consumption disturbs G-protein expression and inhibits Dasarathy S, Dwivedi M, Bhargava DK, Sundaram KR, cyclic AMP-dependent signaling in regenerating rat Ramachandran K. A prospective randomized trial com- liver. 1992;16:1212-9 paring repeated endoscopic sclerotherapy and pro- Dijoud F (see Bissuel et al). 1992;16:1357-61 pranolol in decompensated (Child class B and C) cir- Di Marco C (see Bernardi et al). 1992;16:341-6 rhotic patients. 1992;16:89-94 Dixon RM, Angus PW, Rajagopalan B, Radda GK. *'P Dasarathy S (see Sushma et al). 1992;16:138-44 magnetic resonance spectroscopy detects a functional David M (see Andus et al). 1992;16:749-55 abnormality in liver metabolism after acetaminophen Davies S (see Sallie et al). 1992;16:1206-11 poisoning. 1992;16:943-8 Davies SE (see Palmer et al). 1992;16:682-7 Dodson TF (see Henderson et al). 1992;16:715-8 Davis PA, Leung P, Manns M, Kaplan M, Munoz SJ, Gorin FA, Doherty DG (see Farrant et al). 1992;16:390-5 Dickson ER, Krawitt E, Coppel R, Gershwin ME. M4 and —— (see Underhill et al). 1992;16:1404-8 M9 antibodies in the overlap syndrome of primary biliary Donaldson PT (see Farrant et al). 1992;16:390-5 cirrhosis and chronic active hepatitis: Epitopes or —— (see Underhill et al). 1992;16:1404-8 epiphenomena? 1992;16:1128-36 Donovan JP, Shaw BW Jr, Langnas AN, Sorrell MF. Brain Debray D (see Devictor et al). 1992;16:1156-62 water and acute liver failure: the emerging role of intra- de Castro-e-Silva O Jr (see Roselino et al). 1992;16:1055-60 cranial pressure monitoring. 1992;16:267-8 (Editorial) De Collibus C (see Bernardi et al). 1992;16:341-6 —— (see Langnas et al). 1992;16:1303-5 (HEPATOLOGY De Feo ML (see La Villa et al). 1992;16:156-61 Elsewhere) de Franchis R (see Torgano et al). 1992;16:19-23 Douglas DD (see Rakela and Douglas). 1992;16:497-8 (P - \a- De Giacomo C (see Maggiore and De Giacomo). 1992;16:504 tology Elsewhere) (Letter) Dreher KL (see Meyer et al). 1992;16:204-16 Delhaye M, Gulbis B, Galand P, Mairesse N. Expression of Dubousset A-M (see Devictor et al). 1992;16:1156-62 27-kD heat-shock protein isoforms in human neoplastic Dubuisson L (see Bioulac-Sage et al). 1992;16:418-25 and nonneoplastic liver tissues. 1992;16:382-9 Dufour J-F, Gehr P, Reichen J. Hepatic accumulation of DelValle J (see Raper et al). 1992;16:433-9 lysosomes and defective transcytotic vesicular pathways De Marco M (see Guglielmi et al). 1992;16:1144-9 in cirrhotic rat liver. 1992;16:997-1006 de Medina M (see Caldwell et al). 1992;16:899-905 Durantez A (see Girén et al). 1992;16:664-70 Demetris AJ, Nakamura K, Yagihashi A, Iwaki Y, Takaya S, —— (see Menéndez et al). 1992;16:931-6 Hartman GG, Murase N, Bronsther O, Manez R, Fung Dwivedi M (see Dasarathy et al). 1992;16:89-94 JJ, Iwatsuki S, Starzl TE. A clinicopathological study of human liver allograft recipients harboring preformed E IgG lymphocytotoxic antibodies. 1992;16:671-81 — — (see Furuya et al). 1992;16:1415-22 Eddleston ALWF (see Farrant et al). 1992;16:390-5 Desmet VJ. Congenital diseases of intrahepatic bile ducts: Einarsson K (see Sahlin et al). 1992;16:320-6 variations on the theme “ductal plate malformation”’. Elias E (see Adams et al). 1992;16:810-4 1992;16:1069-83 (Special article) Elmore LW, Sirica AE. Sequential appearance of intestinal Desplanques L (see Devictor et al). 1992;16:1156-62 mucosal cell types in the right and caudate liver lobes of de Tinguy-Moreaud E (see Bioulac-Sage et al). 1992;16:418-25 furan-treated rats. 1992;16:1220-6 De Toni R (see Angeli et al). 1992;16:1389-94 Engel P (see Bastos et al). 1992;16:1434-46 Deulofeu R (see Giménez et al). 1992;16:815-9 Enzan H (see Himeno et al). 1992;16:409-17 Deus J (see Kulisevsky et al). 1992;16:1382-8 Erlinger S. Chronic graft-vs.-host disease of the liver: Another Devaney K, Goodman ZD, Ishak KG. Postinfantile giant-cell indication of ursodeoxycholic acid? 1992;16:1305-7 transformation in hepatitis. 1992;16:327-33 (HEPATOLOGY Elsewhere) Devictor D, Desplanques L, Debray D, Ozier Y, Dubousset Esch O, Spinosa JC, Hamilton RL, Crombie DL, Schteingart A-M, Valayer J, Houssin D, Bernard O, Huault G. CD, Rondinone JF, D’Agostino HB, Lillienau J, Emergency liver transplantation for fulminant liver Hofmann AF. Acute effects of topical methy] tert-butyl failure in infants and children. 1992;16:1156-62 ether or ethyl propionate on gallbladder histology in Dhumeaux D (see Pawlotsky et al). 1992;16:127-31 animals: a comparison of two solvents for contact Dianzani MU (see Parola et al). 1992;16:1014-21 dissolution of cholesterol gallstones. 1992;16:984-91 Di Bisceglie AM, Shindo M, Fong T-L, Fried MW, Swain MG, Estol C (see Lopez et al). 1992;16:162-6 Bergasa NV, Axiotis CA, Waggoner JG, Park Y, Etienne J-P (see Ink et al). 1992;16:912-9 Hoofnagle JH. A pilot study of ribavirin therapy for Eugene C (see Ink et al). 1992;16:912-9 chronic hepatitis C. 1992;16:649-54 Evarts RP (see Hsia et al). 1992;16:1327-33 —— (see Fried et al). 1992;16:861-4 Dick R (see McCormick et al). 1992;16:1180-6 F Dickinson CJ. Hepatitis A— new information on an old virus. 1992;16:1099-1101 (HEPATOLOGY Elsewhere) Fabbri A (see Marchesini et al). 1992;16:149-55 Dickson ER (see Davis et al). 1992;16:1128-36 Fabre M (see Laurent-Puig et al). 1992;16:1171-5 Vol. 16, No. 6, 1992 AUTHOR INDEX Falchetto R (see Bastos et al). 1992;16:1434-46 —— (see Yoshikawa et al). 1992;16:358-64 Fargion S, Piperno A, Cappellini MD, Sampietro M, Fra- Fung JJ (see Demetris et al). 1992;16:671-81 canzani AL, Romano R, Caldarelli R, Marcelli R, Vecchi Furuya T, Murase N, Nakamura K, Woo J, Todo S, Demetris L, Fiorelli G. Hepatitis C virus and porphyria cutanea AJ, Starz] TE. Preformed lymphocytotoxic antibodies: tarda: evidence of a strong association. 1992;16:1322-6 the effects of class, titer and specificity on liver vs. heart —— (see Mandelli et al). 1992;16:956-9 allografts. 1992;16:1415-22 Farrant JM, Doherty DG, Donaldson PT, Vaughan RW, Fusamoto H (see Goto et al). 1992;16:487-93 Hayllar KM, Welsh KI, Eddleston ALWF, Williams R. —— (see Hiramatsu et al). 1992;16:306-11 Amino acid substitutions at position 38 of the DRS —— (see Oshita et al). 1992;16:1007-13 polypeptide confer susceptibility to and protection from —— (see Tanaka et al). 1992;16:479-86 primary sclerosing cholangitis. 1992;16:390-5 Fusconi F (see Barbara et al). 1992;16:132-7 Fattovich G, Giustina G, Brollo L, Guido M, Pontisso P, Fushimi H (see Goto et al). 1992;16:487-93 Noventa F, Alberti A. Therapy for chronic hepatitis B with lymphoblastoid interferon-a and levamisole. 1992; G 16:1115-9 Fernandez CD (see Cascales et al). 1992;16:232-40 Gaal K (see Kamimura et al). 1992;16:448-53 Fernandez-Checa JC (see Hirano et al). 1992;16:1423-7 Gabbiani G (see Rockey et al). 1992;16:776-84 Ferrell L, Wright T, Lake J, Roberts J, Ascher N. Incidence and Gaiani S (see Barbara et al). 1992;16:132-7 diagnostic features of macroregenerative nodules vs. Galand P (see Delhaye et al). 1992;16:382-9 small hepatocellular carcinoma in cirrhotic livers. 1992; Gallati H (see Andus et al). 1992;16:749-55 16:1372-81 Galloway JR (see Henderson et al). 1992;16:715-8 —-—, —-—, Roberts J, Ascher N, Lake J. Hepatitis C viral Garcia-Novo MD (see Ruiz-Moreno et al). 1992;16:882-5 infection in liver transplant recipients. 1992;16:865-76 Garcin H (see Bioulac-Sage et al). 1992;16:418-25 Fevery J (see Gonzalez and Fevery). 1992;16:426-32 Garrido A (see Menéndez et al). 1992;16:931-6 Fiorelli G (see Fargion et al). 1992;16:1322-6 Gasbarrini G (see Andreone et al). 1992;16:550 (Letter) Fischer S (see Berr et al). 1992;16:960-7 —— (see Bernardi et al). 1992;16:341-6 Fitz G. Pumping ions: regulation of intracellular pH in Gatta A (see Angeli et al). 1992;16:1389-94 hepatocytes. 1992;16:271-3 (HEPATOLOGY Elsewhere) Gaudio E (see Riggio et al). 1992;16:785-9 Flejou J-F (see Laurent-Puig et al). 1992;16:1171-5 Gauthier T (see MacIntosh et al). 1992;16:1428-33 Florén C-H (see Liao and Florén). 1992;16:224-31 Gavaler JS, Van Thiel DH. Hormonal status of post- Fong T-L (see Di Bisceglie et al). 1992;16:649-54 menopausal women with alcohol-induced cirrhosis: Fornalé L (see Bernardi et al). 1992;16:341-6 further findings and a review of the literature. 1992;16: Fowler FC, Banks RK, Mailliard ME. Characterization of 312-9 sodium-dependent amino acid transport activity during —— (see Rabinovitz et al). 1992;16:145-8 liver regeneration. 1992;16:1187-94 Gayral F (see Laurent-Puig et al). 1992;16:1171-5 Fracanzani AL (see Fargion et al). 1992;16:1322-6 Gebhardt R. Cell-cell interactions: Clues to hepatocyte hetero- —— (see Mandelli et al). 1992;16:956-9 geneity and beyond? 1992;16:843-5 (HEPATOLOGY Francavilla A, Azzarone A, Carrieri G, Scotti-Foglieni C, Zeng Elsewhere) Q-H, Cillo U, Porter K, Starz] TE. Effect on the canine Gehr P (see Dufour et al). 1992;16:997-1006 Eck fistula liver of intraportal transforming growth Gentilini P (see La Villa et al). 1992;16:156-61 factor-B alone or with hepatic growth factors. 1992;16: Gerbes AL, Witthaut R, Giilberg V, Thibault G, Bilzer M, 1267-70 Jiingst D. Role of the liver in splanchnic extraction of —— (see Guglielmi et al). 1992;16:1144-9 atrial natriuretic factor in the rat. 1992;16:790-3 Franchitto A (see Riggio et al). 1992;16:785-9 —— (see Henriksen et al). 1992;16:1163-70 Franco D (see Laurent-Puig et al). 1992;16:1171-5 Gerok W (see Andus et al). 1992;16:749-55 Frangeul L (see Lunel et al). 1992;16:630-6 Gershwin ME (see Caldwell et al). 1992;16:899-905 Franks JJ (see Kruskal et al). 1992;16:920-3 —— (see Davis et al). 1992;16:1128-36 Frick U (see Berr et al). 1992;16:71-81 Giboudeau J (see Calmus et al). 1992;16:719-23 Fried MW, Korenman JC, Di Bisceglie AM, Park Y, Waggoner Gilles PN, Guerrette DL, Ulevitch RJ, Schreiber RD, Chisari JG, Mitsuya H, Hartman NR, Yarchoan R, Broder S, FV. HBsAg retention sensitizes the hepatocyte to injury Hoofnagle JH. A pilot study of 2’ ,3’-dideoxyinosine for by physiological concentrations of interferon-y. 1992;16: the treatment of chronic hepatitis B. 1992;16:861-4 655-63 —— (see Di Bisceglie et al). 1992;16:649-54 Gillet M (see Bresson-Hadni et al). 1992;16:279-80 (Letter) Friedman SL (see Rockey et al). 1992;16:776-84 Gilmore GT (see Henderson et al). 1992;16:715-8 Fujii T, Kohno M, Hirayama C. Metabolism of !*N-ammonia in Giménez A, Caballeria J, Parés A, Alié S, Deulofeu R, Andreu patients with cirrhosis: a three-compartmental analysis. H, Rodés J. Influence of dietary zinc on hepatic collagen 1992;16:347-52 and prolyl hydroxylase activity in alcoholic rats. 1992; Fujiyoshi M (see Takikawa et al). 1992;16:365-71 16:815-9 Fuke I (see Hiramatsu et al). 1992;16:306-11 —— (see Corrales et al). 1992;16:1922-7 Fukui H (see Goto et al). 1992;16:487-93 Ginés A (see Llach et al). 1992;16:724-7 —— (see Oshita et al). 1992;16:1007-13 Ginés P (see Llach et al). 1992;16:724-7 1518 AUTHOR INDEX HEPATOLOGY Girén JA, Alvarez-Mon M, Menéndez-Caro JL, Abreu L, Gupta S (see Sushma et al). 1992;16:138-44 Albillos A, Manzano L, Durantez A. Increased sponta- —— (see Vemuru et al). 1992;16:968-73 neous and lymphokine-conditioned IgA and IgG syn- thesis by B cells from alcoholic cirrhotic patients. H 1992;16:664-70 —— (see Menéndez et al). 1992;16:931-6 Hacker HJ (see Hagmann et al). 1992;16:1477-84 Giunta A (see Colombo et al). 1992;16:924-30 Hadengue A (see Sogni et al). 1992;16:980-3 Giustina G (see Fattovich et al). 1992;16:1115-9 Hagmann W, Hacker HJ, Buchholz U. Resident mast cells are Goldin RD (see Taylor et al). 1992;16:642-8 the main initiators of anaphylactic leukotriene pro- Gomes MJ (see Bakker et al). 1992;16:404-8 duction in the liver. 1992;16:1477-84 Gémez M (see Landa et al). 1992;16:1474-6 Ham JM (see Henley et al). 1992;16:688-93 Gonzalez AP (see Post et al). 1992;16:803-9 Hamanoue M, Kawaida K, Takao S, Shimazu H, Noji §, Gonzalez J, Fevery J. Spontaneously diabetic biobreeding rats Matsumoto K, Nakamura T. Rapid and marked in- and impairment of bile acid—independent bile flow and duction of hepatocyte growth factor during liver regen- increased biliary bilirubin, calcium and lipid secretion. eration after ischemic or crush injury. 1992;16:1485-92 1992;16:426-32 Hamilton RL (see Esch et al). 1992;16:984-91 Gonzalez P (see Bioulac-Sage et al). 1992;16:418-25 Harada T (see Ito et al). 1992:16:247-54 Gonzalez-Gamarra A (see Solis-Herruzo et al). 1992;16:974-9 Hardison WGM (see Poucell et al). 1992;16:1061-8 Goodman ZD (see Devaney et al). 1992;16:327-33 Hartman GG (see Demetris et al). 1992;16:671-81 Gores GJ (see Sanchez-Urdazpal et al). 1992;16:49-53 Hartman NR (see Fried et al). 1992;16:861-4 —— (see Wiesner et al). 1992;16:1290-9 (Special article) Haruna Y (see Hiramatsu et al). 1992;16:306-11 Goresky CA, Pang KS, Schwab AJ, Barker F III, Cherry WF, Harvey PRC (see Cywes et al). 1992;16:1271-9 Bach GG. Uptake of a protein-bound polar compound, Haussinger D. Nitric oxide and hyperdynamic circulation in acetaminophen sulfate, by perfused rat liver. 1992;16: portal hypertension. 1992;16:1093-4 (HEPATOLOGY 173-90 Elsewhere) —— (see Kassissia et al). 1992;16:763-75 Hay JE (see Wiesner et al). 1992;16:1290-9 (Special article) Gorin FA (see Davis et al). 1992;16:1128-36 Hayakawa T, Katagiri K, Hoshino M, Nakai T, Ohiwa T, Goto M, Takei Y, Kawano S, Tsuji S, Fukui H, Fushimi H, Kumai T, Miyaji M, Takeuchi T, Corasanti J, Boyer JL. Nishimura Y, Kashiwagi T, Fusamoto H, Kamada T. Papaverine inhibits transcytotic vesicle transport and Tumor necrosis factor and endotoxin in the pathogenesis lipid excretion into bile in isolated perfused rat liver. of liver and pulmonary injuries after orthotopic liver 1992;16:1036-42 transplantation in the rat. 1992;16:487-93 Hayashi N (see Hiramatsu et al). 1992;16:306-11 — — (see Oshita et al). 1992;16:1007-13 —— (see Tanaka et al). 1992;16:479-86 Gouillat C (see Bissuel et al). 1992;16:1357-61 Hayllar KM (see Farrant et al). 1992;16:390-5 Govindarajan S (see Ackerman et al). 1992;16:625-9 He D-e (see Sussman et al). 1992;16:60-5 Greenslade L (see McCormick et al). 1992;16:1180-6 Heldwein W (see Beuers et al). 1992;16:707-14 Greig PD (see Cywes et al). 1992;16:1271-9 Henderson JM, Gilmore GT, Mackay GJ, Galloway JR, Dodson Gressner AM, LotfiS, Gressner G, Lahme B. Identification and TF, Kutner MH. Hemodynamics during liver transplan- partial characterization of a hepatocyte-derived factor tation: the interactions between cardiac output and promoting proliferation of cultured fat-storing cells portal venous and hepatic arterial flows. 1992;16:715-8 (parasinusoidal lipocytes). 1992;16:1250-66 Henley KS. Statistics and clinical trials: the case of pred- —— (see Meyer et al). 1992;16:204-16 nisolone in alcoholic hepatitis. 1992;16:1098-9 (HEPA- Gressner G (see Gressner et al). 1992;16:1250-66 TOLOGY Elsewhere) Grigioni W (see Barbara et al). 1992;16:132-7 ——, Lucey MR, Appelman HD, Baliga P, Brown KA, Burtch Grippon P (see Lunel et al). 1992;16:630-6 GD, Campbell DA Jr, Ham JM, Merion RM, Turcotte JG. Groenland TN (see Bakker et al). 1992;16:404-8 Biochemical and histopathological correlation in liver Gross V (see Andus et al). 1992;16:749-55 transplant: the first 180 days. 1992;16:688-93 Groszmann RJ (see Lee et al). 1992;16:1043-8 Henriksen JH, Bendtsen F, Gerbes AL, Christensen NJ, Guechot J (see Calmus et al). 1992;16:719-23 Ring-Larsen H, Sgrensen TIA. Estimated central blood Guerrette DL (see Gilles et al). 1992;16:655-63 volume in cirrhosis: relationship to sympathetic nervous Guglielmi FW, Mastronuzzi T, De Marco M, Laddaga L, activity, B-adrenergic blockade azid atrial natriuretic Panella C, Francavilla A. Oxidative metabolism in factor. 1992;16:1163-70 cirrhotic patients with and without hepatocellular car- Hermans PE (see Paya et al). 1992;16:66-70 cinoma: effects of malnutrition. 1992;16:1144-9 Herrero JI (see Ruiz et al). 1992;16:637-41 Guido M (see Fattovich et al). 1992;16:1115-9 Herve L (see Briand et al). 1992;16:1395-1403 Guirguis S (see Kassissia et al). 1992;16:763-75 Hesselink EJ (see Bakker et al). 1992;16:404-8 Giilberg V (see Gerbes et al). 1992;16:790-3 Higashi Y (see Yoshioka et al). 1992;16:293-9 Gulbis B (see Delhaye et al). 1992;16:382-9 Hijioka T (see Oshita et al). 1992;16:1007-13 Gunji T (see Yoshimi et al). 1992;16:702-6 Himeno H, Saibara T, Onishi S, Yamamoto Y, Enzan H. Giinzler V (see Ala-Kokko et al). 1992;16:167-72 Administration of interleukin-2 induces major histocom- Vol. 16, No. 6, 1992 AUTHOR INDEX patibility complex class II expression on the biliary Imvertarza OC (see Lopez et al). 1992;16:162-6 epithelial cells, possibly through endogenous Inagaki Y (see Adachi et al). 1992;16:1334-7 interferon-y production. 1992;16:409-17 Ink O, Martin T, Poynard T, Reville M, Anciaux M-L, Lenoir Hiraishi H (see Ito et al). 1992;16:247-54 C, Marill J-L, Labadie H, Masliah C, Perrin D, Chaput Hiramatsu N, Hayashi N, Haruna Y, Kasahara A, Fusamoto H, J-C, Vetter D, Eugene C, Lebodic L, Licht H, Etienne Mori C, Fuke I, Okayama H, Kamada T. Immunohis- J-P. Does elective sclerotherapy improve the efficacy of tochemical detection of hepatitis C virus—infected hepa- long-term propranolol for prevention of recurrent tocytes in chronic liver disease with monoclonal anti- bleeding in patients with severe cirrhosis? A prospective bodies to core, envelope and NS3 regions of the hepatitis multicenter randomized trial. 1992;16:912-9 C virus genome. 1992;16:306-11 Inoue S (see Yoshimi et al). 1992;16:702-6 Hirano T, Kaplowitz N, Tsukamoto H, Kamimura §, Ishak KG (see Devaney et al). 1992;16:327-33 Fernandez-Checa JC. Hepatic mitochondrial glu- Ishikawa T (see Yoshioka et al). 1992;16:293-9 tathione depletion and progression of experimental Ishiki Y, Ohnishi H, Muto Y, Matsumoto K, Nakamura T. alcoholic liver disease in rats. 1992;16:1423-7 Direct evidence that hepatocyte growth factor is a Hirayama C (see Fujii et al). 1992;16:347-52 hepatotrophic factor for liver regeneration and has a Hoefs JC. Globulin correction of the albumin gradient: potent antihepatitis effect in vivo. 1992;16:1227-35 correlation with measured serum to ascites colloid Ishimura K (see Kawada et al). 1992;16:462-8 osmotic pressure gradients. 1992;16:396-403 Ishizaka S (see Yoshikawa et al). 1992;16:358-64 Hoek JB (see Ala-Kokko et al). 1992;16:167-72 Ito T (see Tanaka et al). 1992;16:479-86 Hofmann AF (see Esch et al). 1992;16:984-91 Ito Y, Hiraishi H, Razandi M, Terano A, Harada T, Ivey KJ. Holl J (see Berr et al). 1992;16:960-7 Role of cellular superoxide dismutase against reactive Holland PV (see Lee et al). 1992;16:24-30 oxygen metabolite—induced cell damage in cultured rat Holstege A (see Andus et al). 1992;16:749-55 hepatocytes. 1992;16:247-54 Homberg JC (see Abuaf et al). 1992;16:892-8 Itoh Y (see Yoshioka et al). 1992;16:293-9 Homberg J-C (see Lunel et al). 1992;16:630-6 Ivey KJ (see Ito et al). 1992;16:247-54 Honda H (see Utsunomiya et al). 1992;16:694-701 Iwaki Y (see Demetris et al). 1992;16:671-81 Hoofnagle JH (see Di Bisceglie et al). 1992;16:649-54 Iwano K (see Mitsui et al). 1992;16:1109-14 —— (see Fried et al). 1992;16:861-4 Iwatsuki S (see Demetris et al). 1992;16:671-81 Hopf U (see Konig et al). 1992;16:1137-43 —— (see Nonami et al). 1992;16:1195-8 Hornstein B, Stammler L, Bianchi L, Landmann L. Ethi- Izumi N (see Uchihara et al). 1992;16:95-9 nylestradiol increases volume and decreases sinusoidal membrane surface in the rat liver: a stereological J analysis. 1992;16:217-23 Hoshino M (see Hayakawa et al). 1992;16:1036-42 Jain S (see Sushma et al). 1992;16:138-44 Houssin D (see Devictor et al). 1992;16:1156-62 Jansen JBMJ (see Jebbink et al). 1992;16:937-42 Hsia CC, Evarts RP, Nakatsukasa H, Marsden ER, Thor- Jarnagin WR (see Rockey et al). 1992;16:776-84 geirsson SS. Occurrence of oval-type cells in hepatitis B Jebbink MCW, Masclee ADM, van der Kleij FGH, Schipper 4J, virus—associated human hepatocarcinogenesis. 1992;16: Rovati LC, Jansen JBMJ, Lamers CBHW. Effect of 1327-33 loxiglumide and atropine on erythromycin-induced re- Hu W-L, Chindemi PA, Regoeczi E. The perfused liver is duction in gallbladder volume in human subjects. 1992; capable of producing all transferrin glycan variants 16:937-42 found in the sera of intact rats. 1992;16:1049-54 Jeffers LJ (see Caldwell et al). 1992;16:899-905 Huang T-J, Roy Chowdhury J, Lahiri P, Yerneni PC, Bom- Jeffrey AM (see Price et al). 1992;16:8-12 mineni VR, Arias IM, Roy Chowdhury N. Prenatal Johanet C (see Abuaf et al). 1992;16:892-8 diagnosis of bilirubin-UDP-glucuronosyltransferase de- Jiingst D (see Berr et al). 1992;16:960-7 ficiency in rats by genomic DNA analysis. 1992;16: —— (see Gerbes et al). 1992;16:790-3 756-62 Junqué C (see Kulisevsky et al). 1992;16:1382-8 Huault G (see Devictor et al). 1992;16:1156-62 Jwo S-C, Chiu J-H, Chau G-Y, Loong C-C, Lui W-Y. Risk Hultcrantz R (see Lindblad et al). 1992;16:372-81 factors linked to tumor recurrence of human hepatocel- Huraux J-M (see Lunel et al). 1992;16:630-6 lular carcinoma after hepatic resection. 1992;16:1367-71 I K Ikeda N (see Motohashi et al). 1992;16:118-26 Kajikazawa N (see Nomoto et al). 1992;16:1199-1205 Ikeda T, Yanaga K, Kishikawa K, Kakizoe S, Shimada M, Kakizoe S (see Ikeda et al). 1992;16:454-61 Sugimachi K. Ischemic injury in liver transplantation: Kakumu S (see Yoshioka et al). 1992;16:293-9 difference in injury sites between warm and cold Kaler EW (see Kestell et al). 1992;16:1315-21 ischemia in rats. 1992;16:454-61 Kamada T (see Goto et al). 1992;16:487-93 Ilstrup DM (see Paya et al). 1992;16:66-70 —— (see Hiramatsu et al). 1992;16:306-11 Imawari M (see Yoshimi et al). 1992;16:702-6 —— (see Oshita et al). 1992;16:1007-13 1520 AUTHOR INDEX HEPATOLOGY —— (see Tanaka et al). 1992;16:479-86 Kolars JC. Aflatoxin and hepatocellular carcinoma: a useful Kamimura §, Gaal K, Britton RS, Bacon BR, Triadafilopoulos paradigm for environmentally induced carcinogenesis. G, Tsukamoto H. Increased 4-hydroxynonenal levels in 1992;16:848-51 (HEPATOLOGY Elsewhere) experimental alcoholic liver disease: association of lipid Komatsu Y (see Shiratori et al). 1992;16:469-78 peroxidation with liver fibrogenesis. 1992;16:448-53 K6énig V, Bauditz J, Lobeck H, Liisebrink R, Neuhaus P, —— (see Castillo et al). 1992;16:992-6 Blumhardt G, Bechstein WO, Neuhaus R, Steffen R, —— (see Hirano et al). 1992;16:1423-7 Hopf U. Hepatitis C virus reinfection in allografts after Kaneko A (see Tanaka et al). 1992;16:479-86 orthotopic liver transplantation. 1992;16:1137-43 Kaneko S (see Adachi et al). 1992;16:1334-7 Koop DR (see Castillo et al). 1992;16:992-6 —— (see Motohashi et al). 1992;16:118-26 Korenman JC (see Fried et al). 1992;16:861-4 Kaplan M (see Davis et al). 1992;16:1128-36 Kosuge T (see Takayasu et al). 1992;16:906-11 Kaplowitz N (see Hirano et al). 1992;16:1423-7 Kothary PC (see Raper et al). 1992;16:433-9 Karayiannis P (see Taylor et al). 1992;16:642-8 Koussayer T (see Sussman et al). 1992;16:60-5 Kasahara A (see Hiramatsu et al). 1992;16:306-11 Kowalski-Saunders PWJ, Winwood PJ, Arthur MJP, Wright Kashiwagi T (see Goto et al). 1992;16:487-93 R. Reversible inhibition of albumin production by rat —— (see Oshita et al). 1992;16:1007-13 hepatocytes maintained on a _ laminin-rich gel Kassissia I, Rose CP, Goresky CA, Schwab AJ, Bach GG, (Engelbreth-Holm-Swarm) in response to secretory Guirguis S. Flow-limited tracer oxygen distribution in products of Kupffer cells and cytokines. 1992;16:733-41 the isolated perfused rat liver: effects of temperature and Kowdley KV, Tavill AS. An “‘ironic”’ case of mistaken identity. hematocrit. 1992;16:763-75 1992;16:500-1 (Hepatology Elsewhere) Katagiri K (see Hayakawa et al). 1992;16:1036-42 Krawitt E (see Davis et al). 1992;16:1128-36 Katsiyiannakis L (see Sallie et al). 1992;16:1206-11 Krom RAF (see Paya et al). 1992;16:66-70 Katyal SL (see Masuhara et al). 1992;16:1241-9 —— (see Sanchez-Urdazpal et al). 1992;16:49-53 Kawada N, Ueda N, Mizoguchi Y, Kobayashi K, Monna T, —— (see Wiesner et al). 1992;16:1290-9 (Special article) Morisawa S, Ishimura K, Suzuki T, Yamamoto S. Kruis W (see Beuers et al). 1992;16:707-14 Increased 5-lipoxygenase activity in massive hepatic cell Krull N (see Meyer et al). 1992;16:204-16 necrosis in the rat correlates with neutrophil infiltration. Kruskal JB, Robson SC, Franks JJ, Kirsch RE. Elevated 1992;16:462-8 fibrin-related and fibrinogen-related antigens in patients Kawaida K (see Hamanoue et al). 1992;16:1485-92 with liver disease. 1992;16:920-3 Kawano N (see Yoshimi et al). 1992;16:702-6 Kubo R (see Yoshikawa et al). 1992;16:358-64 Kawano S (see Goto et al). 1992;16:487-93 Kuiper J (see Otter et al). 1992;16:54-9 — — (see Oshita et al). 1992;16:1007-13 Kulisevsky J, Pujol J, Balanz6 J, Junqué C, Deus J, Capdevilla Kawase T (see Shiratori et al). 1992;16:469-78 A, Villanueva C. Pallidal hyperintensity on magnetic Kelley A (see Mason et al). 1992;16:36-41 resonance imaging in cirrhotic patients: clinical correla- Kelly JH (see Sussman et al). 1992;16:60-5 tions. 1992;16:1382-8 Kelly RH (see Rabinovitz et al). 1992;16:145-8 Kumai T (see Hayakawa et al). 1992;16:1036-42 Kestell MF, Sekijima J, Lee SP, Park HZ, Long M, Kaler EW. Kutner MH (see Henderson et al). 1992;16:715-8 A calcium binding protein in bile and gallstones. 1992; 16:1315-21 L Kida T, Nakanuma Y, Terada T. Cystic dilatation of peribiliary glands in livers with adult polycystic disease and livers Labadie H (see Ink et al). 1992;16:912-9 with solitary nonparasitic cysts: an autopsy study. Laddaga L (see Guglielmi et al). 1992;16:1144-9 1992;16:334-40 Laffi G (see La Villa et al). 1992;16:156-61 Kim S-K, Belzer FO, Southard JH. Loss of mitochondrial Lahiri P (see Huang et al). 1992;16:756-62 respiratory function and its suppression during cold Lahme B (see Gressner et al). 1992;16:1250-66 ischemic preservation of rat livers with University of Lahoti D (see Sarin et al). 1992;16:1343-9 Wisconsin solution. 1992;16:742-8 Lake J (see Ferrell et al). 1992;16:865-76 Kirsch RE (see Kruskal et al). 1992;16:920-3 Lake JR (see Lidofsky et al). 1992;16:1-7 Kishikawa K (see Ikeda et al). 1992;16:454-61 — — (see Ferrell et al). 1992;16:1372-81 Kiyosawa K (see Nakatsuji et al). 1992;16:300-5 Lamers CBHW (see Jebbink et al). 1992;16:937-42 Kleber G (see Soubrane et al). 1992;16:1447-51 Landa I, Arias J, Gomez M, Quadros M, Moreno A, Balibrea JL. Klein A (see Tur-Kaspa et al). 1992;16:1338-42 Cytoprotective effect of somatostatin in a rat model of Klintmalm GBG (see Paulsen and Klintmalm). 1992;16:100-11 hepatic ischemic reperfusion. 1992;16:1474-6 Knittel T (see Schwégler et al). 1992;16:794-802 Landmann L (see Hornstein et al). 1992;16:217-23 Knot EAR (see Bakker et al). 1992;16:404-8 Langley P (see Panos et al). 1992;16:82-8 Kobayashi K (see Adachi et al). 1992;16:1334-7 Langnas AN, Sorrell MF, Donovan JP, Shaw BW Jr. Surgical —— (see Kawada et al). 1992;16:462-8 management of the Budd-Chiari syndrome: no place for Kohno M (see Fujii et al). 1992;16:347-52 a procrustean bed. 1992;16:1303-5 (HEPATOLOGY Kojima M (see Yotsumoto et al). 1992;16:31-5 Eisewhere) Vol. 16, No. 6, 1992 AUTHOR INDEX 1521 —— (see Donovan et al). 1992;16:267-8 (Editorial) Lopez OL, Estol C, Colina I, Quiroga J, Imvertarza OC, van Laperche S (see Abuaf et al). 1992;16:892-8 Thiel DH. Neurological complications after liver retrans- Larson-Keller JJ (see Paya et al). 1992;16:66-70 plantation. 1992;16:162-6 LaRusso NF (see Wiesner et al). 1992;16:1290-9 (Special Lotfi S (see Gressner et al). 1992;16:1250-66 article) Lu S-N (see Chen et al). 1992;16:1150-5 Laskin DL (see McCloskey et al). 1992;16:191-203 Lucey MR (see Henley et al). 1992;16:688-93 Laskus T (see Cianciara and Laskus). 1992;16:1507-8 (Letter) Ludwig J (see Paya et al). 1992;16:66-70 Laurent-Puig P, Flejou J-F, Fabre M, Bedossa P, Belghiti J, Lui W-Y (see Jwo et al). 1992;16:1367-71 Gayral F, Franco D. Overexpression of p53: a rare event Lunec J (see Challen et al). 1992;16:1362-6 in a large series of white patients with hepatocellular Lunel F, AbuafN , Frangeul L, Grippon P, Perrin M, Le Coz Y, carcinoma. 1992;16:1171-5 Valla D, Borotto E, Yamamoto A-M, Huraux J-M, La Villa G, Romanelli RG, Raggi VC, Tosti-Guerra C, De Feo Opolon P, Homberg J-C. Liver/kidney microsome an- ML, Marra F, Laffi G, Gentilini P. Plasma levels of brain tibody type 1 and hepatitis C virus infection. 1992;16: natriuretic peptide in patients with cirrhosis. 1992;16: 630-6 156-61 Liisebrink R (see K6nig et al). 1992;16:1137-43 Lebodic L (see Ink et al). 1992;16:912-9 Lebrec D (see Sogni et al). 1992;16:980-3 M —— (see Soubrane et al). 1992;16:1447-51 Le Coz Y (see Lunel et al). 1992;16:630-6 Machida A, Ohnuma H, Tsuda F, Munekata E, Tanaka T, Lee F-Y, Albillos A, Colombato LA, Groszmann RJ. The role of Akahane Y, Okamoto H, Mishiro S. Two distinct sub- nitric oxide in the vascular hyporesponsiveness to types of hepatitis C virus defined by antibodies directed methoxamine in portal hypertensive rats. 1992;16: to the putative core protein. 1992;16:886-91 1043-8 MacIntosh E, Gauthier T, Pettigrew N, Minuk G. Liver Lee J-H, Paglieroni TG, Holland PV, Zeldis JB. Chronic regeneration and the effect of exogenous putrescine on hepatitis B virus infection in an anti-HBc—nonreactive regenerative activity after partial hepatectomy in cir- blood donor: Variant virus or defective immune re- rhotic rats. 1992;16:1428-33 sponse? 1992;16:24-30 Mackay GJ (see Henderson et al). 1992;16:715-8 Lee S-D (see Wu et al). 1992;16:1120-7 Mackay IR (see Caldwell et al). 1992;16:899-905 Lee SP (see Kestell et al). 1992;16:1315-21 Maggiore G, De Giacomo C. Efficacy of ursodeoxycholic acid in Lenoir C (see Ink et al). 1992;16:912-9 preventing cholestatic episodes in a patient with benign Lenys D (see Bresson-Hadni et al). 1992;16:279-80 (Letter) recurrent intrahepatic cholestasis. 1992;16:504 (Letter) Leonarduzzi G (see Parola et al). 1992;16:1014-21 Maher JJ (see Rockey et al). 1992;16:776-84 Leung P (see Davis et al). 1992;16:1128-36 Mailliard ME (see Fowler et al). 1992;16:1187-94 Leung PSC (see Caldwell et al). 1992;16:899-905 Mainolfi E (see Adams et al). 1992;16:810-4 Levine BA (see Zhou et al). 1992;16:1236-40 Mairesse N (see Delhaye et al). 1992;16:382-9 Liao W, Florén C-H. Endotoxins inhibit endocytotic catabolism Makuuchi M (see Takayasu et al). 1992;16:906-11 of low-density lipoproteins in Hep G2 cells. 1992;16: Makwana UK (see Sarin et al). 1992;16:1343-9 224-31 Mandelli C, Cesarini L, Piperno A, Fargion S, Fracanzani AL, Licht H (see Ink et al). 1992;16:912-9 Barisani D, Conte D. Saturability of hepatic iron deposits Lidofsky SD, Bass NM, Prager MC, Washington DE, Read AE, in genetic hemochromatosis. 1992;16:956-9 Wright TL, Ascher NL, Roberts JP, Scharschmidt BF, Manez R (see Demetris et al). 1992;16:671-81 Lake JR. Intracranial pressure monitoring and liver Manns M (see Davis et al). 1992;16:1128-36 transplantation for fulminant hepatic failure. 1992; Mantion G (see Bresson-Hadni et al). 1992;16:279-80 (Letter) 16:1-7 Manzano L (see Girén et al). 1992;16:664-70 Ligabue A (see Bernardi et al). 1992;16:341-6 —— (see Menéndez et al). 1992;16:931-6 Lillienau J (see Esch et al). 1992;16:984-91 Marcelli R (see Fargion et al). 1992;16:1322-6 Lin H-C (see Soubrane et al). 1992;16:1447-51 Marchesini G, Bugianesi E, Bianchi G, Fabbri A, Marchi E, Zoli Lin H-M (see Chou et al). 1992;16:13-8 M, Pisi E. Defective methionine metabolism in cirrhosis: Lindblad A, Hultcrantz R, Strandvik B. Bile-duct destruction relation to severity of liver disease. 1992;16:149-55 and collagen deposition: a prominent ultrastructural Marchi E (see Marchesini et al). 1992;16:149-55 feature of the liver in cystic fibrosis. 1992;16:372-81 Marill J-L (see Ink et al). 1992;16:912-9 Llach J, Rimola A, Navasa M, Ginés P, Salmerén JM, Ginés A, Marin MG (see Puoti et al). 1992;16:877-81 Arroyo V, Rodés J. Incidence and predictive factors of Marra F (see La Villa et al). 1992;16:156-61 first episode of spontaneous bacterial peritonitis in Marsden ER (see Hsia et al). 1992;16:1327-33 cirrhosis with ascites: relevance of ascitic fluid protein Marsh DC (see Vreugdenhil et al). 1992;16:241-6 concentration. 1992;16:724-7 Martin P, Friedman L. Hepatitis C: evaluating the seropositive Lobeck H (see Kénig et al). 1992;16:1137-43 blood donor (1992;15:967-9). 1992;16:501 (Correction) Long M (see Kestell et al). 1992;16:1315-21 Martin-Sanz P (see Cascales et al). 1992;16:232-40 Loong C-C (see Jwo et al). 1992;16:1367-71 Martin T (see Ink et al). 1992;16:912-9 1522 AUTHOR INDEX HEPATOLOGY Martini E (see Abuaf et al). 1992;16:892-8 Meyer zum Biischenfelde K-H (see Schwégler et al). 1992;16: Marumo F (see Uchihara et al). 1992;16:95-9 794-802 Masclee ADM (see Jebbink et al). 1992;16:937-42 Mieli-Vergani G (see Sallie et al). 1992;16:1206-11 Masliah C (see Ink et al). 1992;16:912-9 Miguet J-P (see Bresson-Hadni et al). 1992;16:279-80 (Letter) Mason A, Yoffe B, Noonan C, Mearns M, Campbell C, Kelley Mikami M (see Mitaka et al). 1992;16:440-7 A, Perrillo RP. Hepatitis B virus DNA in peripheral- Miller C (see Theise et al). 1992;16:949-55 blood mononuclear cells in chronic hepatitis B after Minagawa H (see Tanaka et al). 1992;16:1409-14 HBsAg clearance. 1992;16:36-41 Minamishima Y (see Tanaka et al). 1992;16:1409-14 Mastronuzzi T (see Guglielmi et al). 1992;16:1144-9 Minuk G (see MacIntosh et al). 1992;16:1428-33 Masuhara M, Katyal SL, Nakamura T, Shinozuka H. Differ- Mishiro S (see Machida et al). 1992;16:886-91 ential expression of hepatocyte growth factor, trans- —— (see Mitsui et al). 1992;16:1109-14 forming growth factor-a and transforming growth —— (see Okada et al). 1992;16:619-24 factor-B, messenger RNAs in two experimental models —— (see Yotsumoto et al). 1992;16:31-5 of liver cell proliferation. 1992;16:1241-9 Mitaka T, Mikami M, Sattler GL, Pitot HC, Mochizuki Y. Small Masuko K (see Mitsui et al). 1992;16:1109-14 cell colonies appear in the primary culture of adult rat Mato JM (see Corrales et al). 1992;16:1922-7 hepatocytes in the presence of nicotinamide and epi- Matsumata T (see Utsunomiya et al). 1992;16:694-701 dermal growth factor. 1992;16:440-7 Matsumoto A (see Nakatsuji et al). 1992;16:300-5 Mitsui T, Iwano K, Masuko K, Yamazaki C, Okamoto H, Tsuda Matsumoto K (see Hamanoue et al). 1992;16:1485-92 F, Tanaka T, Mishiro S. Hepatitis C virus infection in —— (see Ishiki et al). 1992;16:1227-35 medical personnel after needlestick accident. 1992;16: Matsumura K (see Yoshikawa et al). 1992;16:358-64 1109-14 Matsumura Y (see Yoshikawa et al). 1992;16:358-64 Mitsuya H (see Fried et al). 1992;16:861-4 Matsunaga T (see Oshita et al). 1992;16:1007-13 Miyai K (see Poucell et al). 1992;16:1061-8 Matsushita E (see Adachi et al). 1992;16:1334-7 Miyaji M (see Hayakawa et al). 1992;16:1036-42 Maus TP (see Sanchez-Urdazpal et al). 1992;16:49-53 Miyoshi E (see Tanaka et al). 1992;16:479-86 Mazziotti A (see Barbara et al). 1992;16:132-7 Mizoguchi Y (see Kawada et al). 1992;16:462-8 McCloskey TW, Todaro JA, Laskin DL. Lipopolysaccharide Mochizuki Y (see Mitaka et al). 1992;16:440-7 treatment of rats alters antigen expression and oxidative Moncada S (see Whittle and Moncada). 1992;16:1089-92 metabolism in hepatic macrophages and endothelial (Editorial) cells. 1992;16:191-203 Monna T (see Kawada et al). 1992;16:462-8 McCollum MO (see Zhou et al). 1992;16:1236-40 Moore SB (see Paya et al). 1992;16:66-70 McCormick PA, Biagini MR, Dick R, Greenslade L, Chin J, —— (see Sanchez-Urdazpal et al). 1992;16:49-53 Cardin F, Wagstaff D, McIntyre N, Burroughs AK. Morali GA, Tobe SW, Skorecki KL, Blendis LM. Refractory Octreotide inhibits the meal-induced increases in the ascites: modulation of atrial natriuretic factor unrespon- portal venous pressure of cirrhotic patients with portal siveness by mannitol. 1992;16:42-8 hypertension: a double-blind, placebo-controlled study. Moreau R (see Sogni et al). 1992;16:980-3 1992;16:1180-6 Moreno A (see Landa et al). 1992;16:1474-6 McHutchison JG (see Ackerman et al). 1992;16:625-9 Moretti R (see Riggio et al). 1992;16:785-9 McIntyre N (see McCormick et al). 1992;16:1180-6 Morgan GR (see Cywes et al). 1992;16:1271-9 Mearns M (see Mason et al). 1992;16:36-41 Morgan TR, Mendenhall CL. Nutritional therapy for alcoholic Mendenhall CL (see Morgan and Mendenhall). 1992;16:845-8 hepatitis: Are we there yet? 1992;16:845-8 (HEPA- (HEPATOLOGY Elsewhere) TOLOGY Elsewhere) Menéndez JL, Girén JA, Manzano L, Garrido A, Abreu L, Mori C (see Hiramatsu et al). 1992;16:306-11 Albillos A, Durantez A, Alvarez-Mon M. Deficient Mori R (see Tanaka et al). 1992;16:1409-14 interleukin-2 responsiveness of T lymphocytes from Morisawa S (see Kawada et al). 1992;16:462-8 patients with primary biliary cirrhosis. 1992;16: Morishima T (see Yoshioka et al). 1992;16:293-9 931-6 Moriyama N (see Takayasu et al). 1992;16:906-11 Menéndez-Caro JL (see Girén et al). 1992;16:664-70 Mortensen PB. The effect of oral-administered lactulose on Menger MD (see Post et al). 1992;16:803-9 colonic nitrogen metabolism and excretion. 1992;16: Menon F (see Angeli et al). 1992;16:1389-94 1350-6 Merion RM (see Henley et al). 1992;16:688-93 Motohashi I, Okudaira M, Takai T, Kaneko S, Ikeda N. Merkel C (see Angeli et al). 1992;16:1389-94 Morphological differences between hepatocellular car- Merli M (see Riggio et al). 1992;16:785-9 cinoma and hepatocellular carcinomalike lesions. 1992; Metreau J-M (see Pawlotsky et al). 1992;16:127-31 16:118-26 Metselaar HJ (see Bakker et al). 1992;16:404-8 Mowat A (see Sallie et al). 1992;16:1206-11 Meyer DH, Krull N, Dreher KL, Gressner AM. Biglycan and Muller S (see Briand et al). 1992;16:1395-1403 decorin gene expression in normal and fibrotic rat liver: Munekata E (see Machida et al). 1992;16:886-91 cellular localization and regulatory factors. 1992;16: Munoz SJ (see Davis et al). 1992;16:1128-36 204-16 Munioz-Yagtie MT (see Solis-Herruzo et al). 1992;16:974-9

See more

The list of books you might like

Upgrade Premium
Most books are stored in the elastic cloud where traffic is expensive. For this reason, we have a limit on daily download.
DMCA & Copyright: Dear all, most of the website is community built, users are uploading hundred of books everyday, which makes really hard for us to identify copyrighted material, please contact us if you want any material removed.
Copyright @ PDFdrive.to, 2022 | We love our users